"Study_ID"	"Patient_ID"	"Sequencing_type"	"Treatment_Outcome"	"PFS_months"	"Histology"	"Smoking_History"	"Diagnosis_Age"	"Sex"	"Stage_at_diagnosis"	"PD.L1_Expression"	"TMB"	"NFKBIA"	"NOTCH2"	"ERBB4"	"ASXL1"	"MET"	"CIC"	"TET1"	"PGR"	"PIK3C2G"	"NUF2"	"PTPRD"	"EPHA7"	"MAX"	"JAK3"	"ABL1"	"MDC1"	"EPHB1"	"INHBA"	"PIK3C3"	"PIM1"	"BRIP1"	"PPM1D"	"CDC73"	"TENT5C"	"ATM"	"FGFR4"	"PARP1"	"FOXL2"	"MED12"	"ZFHX3"	"EPHA3"	"TSC2"	"MGA"	"RET"	"EPHA5"	"NTRK3"	"STAT3"	"CD79B"	"MRE11"	"PPP2R1A"	"NF2"	"PAX5"	"NOTCH1"	"BRCA2"	"HGF"	"BCOR"	"ERCC4"	"CARD11"	"PIK3CG"	"FLT3"	"POLE"	"KEAP1"	"KRAS"	"POLD1"	"STK11"	"TP53"	"MSH2"	"EGFR"	"PTEN"	"MSI_MSISensorPro"	"Pan_2020_muts"	"DCB_genes"	"NDB_genes"
"1"	"Hellmann_2018"	"nsclc_mskcc_2018p1"	"WES"	"Non-Responder"	1.4127	"Lung Adenocarcinoma"	"Former"	70	"Female"	""	"Weak"	2.06666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2"	"Hellmann_2018"	"nsclc_mskcc_2018p10"	"WES"	"Non-Responder"	5.4209	"Lung Adenocarcinoma"	"Former"	72	"Male"	""	"Weak"	8.96666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	NA	1	2	0
"3"	"Hellmann_2018"	"nsclc_mskcc_2018p11"	"WES"	"Responder"	7.8193	"Lung Adenocarcinoma"	"Never"	58	"Female"	""	"Negative"	1.06666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"4"	"Hellmann_2018"	"nsclc_mskcc_2018p12"	"WES"	"Responder"	26.152	"Lung Adenocarcinoma"	"Former"	82	"Male"	""	"Weak"	7.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"5"	"Hellmann_2018"	"nsclc_mskcc_2018p13"	"WES"	"Responder"	23.9507	"Lung Adenocarcinoma"	"Never"	76	"Male"	""	""	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"6"	"Hellmann_2018"	"nsclc_mskcc_2018p14"	"WES"	"Non-Responder"	1.6756	"Lung Adenocarcinoma"	"Former"	43	"Female"	""	"Weak"	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"7"	"Hellmann_2018"	"nsclc_mskcc_2018p15"	"WES"	"Non-Responder"	0.0329	"Lung Adenocarcinoma"	"Current"	53	"Female"	""	"Negative"	7.5	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	2	1	1
"8"	"Hellmann_2018"	"nsclc_mskcc_2018p16"	"WES"	"Non-Responder"	3.6468	"Lung Adenocarcinoma"	"Never"	67	"Male"	""	"Negative"	0.733333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"9"	"Hellmann_2018"	"nsclc_mskcc_2018p17"	"WES"	"Responder"	12.0903	"Lung Adenocarcinoma"	"Never"	68	"Female"	""	"Strong"	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"10"	"Hellmann_2018"	"nsclc_mskcc_2018p18"	"WES"	"Responder"	29.7331	"Lung Adenocarcinoma"	"Former"	69	"Female"	""	"Weak"	25.4	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	6	1	0
"11"	"Hellmann_2018"	"nsclc_mskcc_2018p19"	"WES"	"Responder"	28.7803	"Lung Adenocarcinoma"	"Former"	59	"Male"	""	"Weak"	25.0333333333	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	5	0	0
"12"	"Hellmann_2018"	"nsclc_mskcc_2018p2"	"WES"	"Responder"	6.8008	"Lung Adenocarcinoma"	"Former"	72	"Male"	""	"Strong"	7.36666666667	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"13"	"Hellmann_2018"	"nsclc_mskcc_2018p20"	"WES"	"Non-Responder"	1.4456	"Lung Adenocarcinoma"	"Current"	54	"Male"	""	"Weak"	5.46666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	NA	1	1	1
"14"	"Hellmann_2018"	"nsclc_mskcc_2018p21"	"WES"	"Responder"	21.5852	"Lung Adenocarcinoma"	"Former"	74	"Female"	""	"Weak"	9.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	2	1	0
"15"	"Hellmann_2018"	"nsclc_mskcc_2018p22"	"WES"	"Non-Responder"	2.4969	"Lung Adenocarcinoma"	"Former"	72	"Male"	""	"Negative"	4.46666666667	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	NA	1	0	1
"16"	"Hellmann_2018"	"nsclc_mskcc_2018p23"	"WES"	"Responder"	7.9836	"Lung Adenocarcinoma"	"Former"	75	"Female"	""	"Weak"	7.13333333333	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	3	1	0
"17"	"Hellmann_2018"	"nsclc_mskcc_2018p24"	"WES"	"Non-Responder"	2.2669	"Lung Adenocarcinoma"	"Former"	85	"Female"	""	"Negative"	1.46666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"18"	"Hellmann_2018"	"nsclc_mskcc_2018p25"	"WES"	"Responder"	22.1437	"Lung Adenocarcinoma"	"Former"	65	"Male"	""	"Weak"	11.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"19"	"Hellmann_2018"	"nsclc_mskcc_2018p26"	"WES"	"Responder"	23	"Lung Adenocarcinoma"	"Current"	60	"Female"	""	"Weak"	43.3	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	NA	6	1	0
"20"	"Hellmann_2018"	"nsclc_mskcc_2018p27"	"WES"	"Non-Responder"	4.1068	"Lung Adenocarcinoma"	"Current"	55	"Male"	""	""	5.73333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"21"	"Hellmann_2018"	"nsclc_mskcc_2018p28"	"WES"	"Responder"	17.0513	"Lung Adenocarcinoma"	"Former"	77	"Female"	""	"Strong"	5.7	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"22"	"Hellmann_2018"	"nsclc_mskcc_2018p29"	"WES"	"Non-Responder"	2.5955	"Lung Adenocarcinoma"	"Current"	50	"Female"	""	"Negative"	14.6333333333	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"23"	"Hellmann_2018"	"nsclc_mskcc_2018p3"	"WES"	"Non-Responder"	1.4784	"Lung Adenocarcinoma"	"Never"	61	"Female"	""	"Strong"	0.366666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"24"	"Hellmann_2018"	"nsclc_mskcc_2018p30"	"WES"	"Responder"	21.191	"Lung Adenocarcinoma"	"Former"	75	"Male"	""	"Weak"	6.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"25"	"Hellmann_2018"	"nsclc_mskcc_2018p31"	"WES"	"Non-Responder"	2.3326	"Lung Adenocarcinoma"	"Current"	67	"Female"	""	"Weak"	5.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	0	0	0	NA	1	1	0
"26"	"Hellmann_2018"	"nsclc_mskcc_2018p32"	"WES"	"Responder"	18.9897	"Lung Adenocarcinoma"	"Former"	50	"Female"	""	"Strong"	12.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	1	0	0	0	NA	3	1	1
"27"	"Hellmann_2018"	"nsclc_mskcc_2018p33"	"WES"	"Responder"	21.6181	"Lung Adenocarcinoma"	"Former"	74	"Male"	""	"Negative"	11.0666666667	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"28"	"Hellmann_2018"	"nsclc_mskcc_2018p34"	"WES"	"Responder"	22.34	"Lung Adenocarcinoma"	"Former"	76	"Male"	""	"Strong"	1.16666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"29"	"Hellmann_2018"	"nsclc_mskcc_2018p35"	"WES"	"Non-Responder"	2.3326	"Lung Adenocarcinoma"	"Former"	66	"Female"	""	""	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"30"	"Hellmann_2018"	"nsclc_mskcc_2018p36"	"WES"	"Responder"	13.3388	"Lung Adenocarcinoma"	"Former"	62	"Female"	""	"Negative"	3.26666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	0	0	1
"31"	"Hellmann_2018"	"nsclc_mskcc_2018p37"	"WES"	"Responder"	19.0226	"Lung Adenocarcinoma"	"Former"	57	"Female"	""	"Strong"	6.36666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	1	0	0	0	NA	3	2	0
"32"	"Hellmann_2018"	"nsclc_mskcc_2018p38"	"WES"	"Responder"	7.8193	"Lung Adenocarcinoma"	"Former"	66	"Male"	""	""	4.7	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"33"	"Hellmann_2018"	"nsclc_mskcc_2018p39"	"WES"	"Non-Responder"	0.03	"Lung Adenocarcinoma"	"Never"	68	"Female"	""	"Weak"	0.366666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"34"	"Hellmann_2018"	"nsclc_mskcc_2018p4"	"WES"	"Non-Responder"	3.7782	"Lung Adenocarcinoma"	"Current"	64	"Male"	""	"Weak"	3.73333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	NA	0	1	0
"35"	"Hellmann_2018"	"nsclc_mskcc_2018p40"	"WES"	"Responder"	8.115	"Lung Adenocarcinoma"	"Former"	73	"Male"	""	"Weak"	9.86666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	1	1	0
"36"	"Hellmann_2018"	"nsclc_mskcc_2018p41"	"WES"	"Responder"	13.5359	"Lung Adenocarcinoma"	"Former"	53	"Male"	""	"Negative"	30.0333333333	0	0	1	0	0	0	1	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	10	0	0
"37"	"Hellmann_2018"	"nsclc_mskcc_2018p42"	"WES"	"Non-Responder"	3.9425	"Lung Adenocarcinoma"	"Former"	59	"Male"	""	"Weak"	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"38"	"Hellmann_2018"	"nsclc_mskcc_2018p43"	"WES"	"Non-Responder"	5.0924	"Lung Adenocarcinoma"	"Former"	58	"Female"	""	"Negative"	8.76666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"39"	"Hellmann_2018"	"nsclc_mskcc_2018p44"	"WES"	"Non-Responder"	0.3285	"Lung Adenocarcinoma"	"Former"	63	"Male"	""	"Weak"	4.76666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"40"	"Hellmann_2018"	"nsclc_mskcc_2018p45"	"WES"	"Non-Responder"	2.2341	"Lung Adenocarcinoma"	"Never"	56	"Male"	""	"Weak"	4.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"41"	"Hellmann_2018"	"nsclc_mskcc_2018p46"	"WES"	"Non-Responder"	3.3183	"Lung Adenocarcinoma"	"Former"	69	"Male"	""	"Strong"	11.5666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	NA	3	1	0
"42"	"Hellmann_2018"	"nsclc_mskcc_2018p47"	"WES"	"Non-Responder"	2.1027	"Lung Adenocarcinoma"	"Former"	66	"Male"	""	"Weak"	23.2666666667	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"43"	"Hellmann_2018"	"nsclc_mskcc_2018p48"	"WES"	"Non-Responder"	2.2998	"Lung Adenocarcinoma"	"Never"	51	"Male"	""	"Negative"	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	NA	0	0	0
"44"	"Hellmann_2018"	"nsclc_mskcc_2018p49"	"WES"	"Responder"	11.6632	"Lung Adenocarcinoma"	"Never"	55	"Female"	""	"Negative"	3.53333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	NA	1	0	1
"45"	"Hellmann_2018"	"nsclc_mskcc_2018p5"	"WES"	"Responder"	7.5565	"Lung Adenocarcinoma"	"Never"	57	"Male"	""	"Negative"	4.66666666667	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	4	0	0
"46"	"Hellmann_2018"	"nsclc_mskcc_2018p50"	"WES"	"Responder"	10.6119	"Lung Adenocarcinoma"	"Former"	63	"Male"	""	"Negative"	5.73333333333	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"47"	"Hellmann_2018"	"nsclc_mskcc_2018p51"	"WES"	"Responder"	29.9302	"Lung Adenocarcinoma"	"Former"	56	"Female"	""	"Negative"	46.0666666667	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	1	0	0	0	NA	9	1	0
"48"	"Hellmann_2018"	"nsclc_mskcc_2018p52"	"WES"	"Responder"	30.3244	"Lung Adenocarcinoma"	"Former"	67	"Male"	""	"Negative"	5.93333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	NA	0	0	1
"49"	"Hellmann_2018"	"nsclc_mskcc_2018p53"	"WES"	"Non-Responder"	1.3799	"Lung Adenocarcinoma"	"Former"	46	"Female"	""	"Weak"	8.66666666667	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"50"	"Hellmann_2018"	"nsclc_mskcc_2018p54"	"WES"	"Non-Responder"	5.1581	"Lung Adenocarcinoma"	"Current"	42	"Female"	""	"Negative"	12.6666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	1	NA	2	1	0
"51"	"Hellmann_2018"	"nsclc_mskcc_2018p55"	"WES"	"Non-Responder"	2.1027	"Lung Adenocarcinoma"	"Former"	71	"Male"	""	"Negative"	6.83333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	1	0	0	0	NA	3	1	1
"52"	"Hellmann_2018"	"nsclc_mskcc_2018p56"	"WES"	"Responder"	6.5051	"Lung Adenocarcinoma"	"Former"	63	"Female"	""	"Negative"	5.9	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	1	1	1
"53"	"Hellmann_2018"	"nsclc_mskcc_2018p57"	"WES"	"Non-Responder"	2.037	"Lung Adenocarcinoma"	"Former"	61	"Female"	""	"Negative"	4.43333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	0	1	1
"54"	"Hellmann_2018"	"nsclc_mskcc_2018p58"	"WES"	"Non-Responder"	1.8727	"Lung Adenocarcinoma"	"Never"	56	"Female"	""	"Weak"	5.06666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"55"	"Hellmann_2018"	"nsclc_mskcc_2018p59"	"WES"	"Non-Responder"	2.3326	"Lung Adenocarcinoma"	"Never"	56	"Female"	""	"Weak"	1.66666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"56"	"Hellmann_2018"	"nsclc_mskcc_2018p6"	"WES"	"Non-Responder"	3.7125	"Lung Adenocarcinoma"	"Former"	67	"Female"	""	"Negative"	1.86666666667	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"57"	"Hellmann_2018"	"nsclc_mskcc_2018p60"	"WES"	"Responder"	24.3121	"Lung Adenocarcinoma"	"Former"	73	"Female"	""	"Weak"	49.1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	1	0	0	NA	8	3	0
"58"	"Hellmann_2018"	"nsclc_mskcc_2018p61"	"WES"	"Non-Responder"	1.7084	"Lung Adenocarcinoma"	"Former"	72	"Male"	""	"Negative"	18.6333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	2	1	0
"59"	"Hellmann_2018"	"nsclc_mskcc_2018p62"	"WES"	"Responder"	22.9979	"Lung Adenocarcinoma"	"Never"	87	"Male"	""	"Weak"	49.9	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	9	0	0
"60"	"Hellmann_2018"	"nsclc_mskcc_2018p63"	"WES"	"Responder"	21.8809	"Lung Adenocarcinoma"	"Former"	75	"Male"	""	"Strong"	0.566666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"61"	"Hellmann_2018"	"nsclc_mskcc_2018p64"	"WES"	"Responder"	20.0411	"Lung Adenocarcinoma"	"Current"	74	"Female"	""	"Weak"	0.866666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"62"	"Hellmann_2018"	"nsclc_mskcc_2018p65"	"WES"	"Non-Responder"	4.7639	"Lung Adenocarcinoma"	"Never"	69	"Female"	""	"Negative"	1.66666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"63"	"Hellmann_2018"	"nsclc_mskcc_2018p66"	"WES"	"Non-Responder"	0.0329	"Lung Adenocarcinoma"	"Former"	76	"Male"	""	"Negative"	7.33333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	4	0	0
"64"	"Hellmann_2018"	"nsclc_mskcc_2018p67"	"WES"	"Non-Responder"	2.5298	"Lung Adenocarcinoma"	"Former"	71	"Female"	""	"Weak"	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"65"	"Hellmann_2018"	"nsclc_mskcc_2018p68"	"WES"	"Responder"	7.9507	"Lung Adenocarcinoma"	"Former"	61	"Male"	""	"Weak"	16.8333333333	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	NA	4	0	1
"66"	"Hellmann_2018"	"nsclc_mskcc_2018p69"	"WES"	"Non-Responder"	2.6283	"Lung Adenocarcinoma"	"Former"	67	"Female"	""	"Weak"	2.03333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"67"	"Hellmann_2018"	"nsclc_mskcc_2018p7"	"WES"	"Responder"	38.6037	"Lung Adenocarcinoma"	"Former"	56	"Male"	""	"Weak"	8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"68"	"Hellmann_2018"	"nsclc_mskcc_2018p70"	"WES"	"Non-Responder"	1.2813	"Lung Adenocarcinoma"	"Former"	83	"Male"	""	""	9.83333333333	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"69"	"Hellmann_2018"	"nsclc_mskcc_2018p71"	"WES"	"Non-Responder"	3.5154	"Lung Adenocarcinoma"	"Former"	71	"Female"	""	"Weak"	0.866666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"70"	"Hellmann_2018"	"nsclc_mskcc_2018p72"	"WES"	"Non-Responder"	2.2998	"Lung Adenocarcinoma"	"Never"	47	"Male"	""	"Weak"	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	0	1	1
"71"	"Hellmann_2018"	"nsclc_mskcc_2018p73"	"WES"	"Responder"	16.46	"Lung Adenocarcinoma"	"Former"	57	"Female"	""	"Weak"	39.6	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"72"	"Hellmann_2018"	"nsclc_mskcc_2018p74"	"WES"	"Responder"	7.9836	"Lung Adenocarcinoma"	"Former"	42	"Male"	""	"Weak"	23.2666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	1	NA	4	3	0
"73"	"Hellmann_2018"	"nsclc_mskcc_2018p75"	"WES"	"Responder"	14.883	"Lung Adenocarcinoma"	"Former"	51	"Female"	""	"Negative"	12.9666666667	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	3	0	0
"74"	"Hellmann_2018"	"nsclc_mskcc_2018p8"	"WES"	"Non-Responder"	2.9897	"Lung Adenocarcinoma"	"Former"	58	"Male"	""	"Strong"	5.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"75"	"Hellmann_2018"	"nsclc_mskcc_2018p9"	"WES"	"Responder"	7.7536	"Lung Adenocarcinoma"	"Former"	68	"Female"	""	"Weak"	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"76"	"Jordan_2017"	"P-0000082"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	56	"Male"	"IA"	""	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"77"	"Jordan_2017"	"P-0000208"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	68	"Female"	"IV"	""	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"78"	"Jordan_2017"	"P-0000458"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Male"	"IV"	""	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"79"	"Jordan_2017"	"P-0000459"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	77	"Male"	"IV"	""	7.76408710418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	NA	0	0	1
"80"	"Jordan_2017"	"P-0000628"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	51	"Male"	"IV"	""	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"81"	"Jordan_2017"	"P-0000681"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	66	"Female"	"IV"	""	18.8556401102	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	NA	4	1	1
"82"	"Jordan_2017"	"P-0000731"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	72	"Female"	"IV"	""	6.65493180359	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"83"	"Jordan_2017"	"P-0000894"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	77	"Male"	"IV"	""	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"84"	"Jordan_2017"	"P-0000913"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	54	"Female"	"IV"	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"85"	"Jordan_2017"	"P-0000978"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	57	"Female"	"IV"	""	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"86"	"Jordan_2017"	"P-0001722"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	75	"Male"	"IV"	""	7.76408710418	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"87"	"Jordan_2017"	"P-0001955"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	29	"Female"	"IIIA"	""	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	NA	0	1	0
"88"	"Jordan_2017"	"P-0002320"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	56	"Male"	"IV"	""	6.65493180359	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"89"	"Jordan_2017"	"P-0002916"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	34	"Female"	"IV"	""	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"90"	"Jordan_2017"	"P-0003278"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Current"	54	"Female"	"IV"	""	12.723356069	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	4	0	0
"91"	"Jordan_2017"	"P-0003495"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	87	"Female"	"IV"	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"92"	"Jordan_2017"	"P-0003628"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	60	"Male"	"IV"	""	12.723356069	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"93"	"Jordan_2017"	"P-0003773"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Female"	"IV"	""	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"94"	"Jordan_2017"	"P-0003913"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	42	"Female"	"IV"	""	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"95"	"Jordan_2017"	"P-0004099"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	57	"Male"	"IIIA"	""	12.723356069	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"96"	"Jordan_2017"	"P-0004103"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	38	"Female"	"IV"	""	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"97"	"Jordan_2017"	"P-0004232"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	66	"Male"	"IIA"	""	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"98"	"Jordan_2017"	"P-0004279"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Female"	"IV"	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"99"	"Jordan_2017"	"P-0004342"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	74	"Female"	"IV"	""	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"100"	"Jordan_2017"	"P-0004752"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	82	"Male"	"IV"	""	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"101"	"Jordan_2017"	"P-0004927"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	61	"Female"	"IV"	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"102"	"Jordan_2017"	"P-0005178"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	50	"Female"	"IV"	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	NA	0	1	1
"103"	"Jordan_2017"	"P-0005179"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	70	"Female"	"IV"	""	13.7020757666	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	1	1	0
"104"	"Jordan_2017"	"P-0005259"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Male"	"IV"	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	NA	1	0	1
"105"	"Jordan_2017"	"P-0005483"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	57	"Female"	"IV"	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"106"	"Jordan_2017"	"P-0005871"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	46	"Male"	"IV"	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	NA	0	0	0
"107"	"Jordan_2017"	"P-0005897"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	43	"Male"	"IIB"	""	5.87231818569	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	NA	3	0	0
"108"	"Jordan_2017"	"P-0006268"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	70	"Male"	"IV"	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"109"	"Jordan_2017"	"P-0006561"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	49	"Female"	"IV"	""	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"110"	"Jordan_2017"	"P-0007088"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	41	"Female"	"IV"	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"111"	"Jordan_2017"	"P-0007582"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	81	"Male"	"IIIA"	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	NA	1	1	1
"112"	"Jordan_2017"	"P-0007977"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	68	"Female"	"IV"	""	5.87231818569	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	1	0	0
"113"	"Jordan_2017"	"P-0008160"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Male"	"IV"	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"114"	"Jordan_2017"	"P-0008322"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	62	"Male"	"IV"	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"115"	"Jordan_2017"	"P-0008332"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	51	"Female"	"IV"	""	3.91487879046	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"116"	"Jordan_2017"	"P-0008589"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	51	"Female"	"IIIB"	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"117"	"Jordan_2017"	"P-0008757"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	77	"Male"	"IV"	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"118"	"Jordan_2017"	"P-0009655"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	68	"Female"	"IV"	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"119"	"Jordan_2017"	"P-0009680"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	56	"Female"	"IV"	""	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	1	0	1
"120"	"Jordan_2017"	"P-0010257"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	54	"Female"	"IV"	""	9.78719697615	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"121"	"Rivzi_2015"	"luad_mskcc_2015_15"	"WES"	"Responder"	8.4	"Lung Adenocarcinoma"	"Former"	59	"Male"	""	"Strong"	7.83333333333	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	3	1	0
"122"	"Rivzi_2015"	"luad_mskcc_2015_33"	"WES"	"Non-Responder"	1.8	"Lung Adenocarcinoma"	"Former"	64	"Male"	""	""	1.13333333333	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"123"	"Rivzi_2015"	"luad_mskcc_2015_22"	"WES"	"Non-Responder"	6.5	"Lung Adenocarcinoma"	"Former"	73	"Female"	""	""	4.73333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	NA	1	1	0
"124"	"Rivzi_2015"	"luad_mskcc_2015_9"	"WES"	"Responder"	14.5	"Lung Adenocarcinoma"	"Former"	57	"Male"	""	"Strong"	10.5666666667	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	4	1	0
"125"	"Rivzi_2015"	"luad_mskcc_2015_18"	"WES"	"Responder"	9.8	"Lung Adenocarcinoma"	"Current"	61	"Female"	""	"Strong"	7.56666666667	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"126"	"Rivzi_2015"	"luad_mskcc_2015_24"	"WES"	"Non-Responder"	1.9	"Lung Adenocarcinoma"	"Never"	50	"Male"	""	""	4.33333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"127"	"Rivzi_2015"	"luad_mskcc_2015_30"	"WES"	"Responder"	8.3	"Lung Adenocarcinoma"	"Former"	80	"Male"	""	"Negative"	1.83333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"128"	"Rivzi_2015"	"luad_mskcc_2015_23"	"WES"	"Non-Responder"	1.9	"Lung Adenocarcinoma"	"Current"	59	"Male"	""	"Negative"	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	NA	2	0	0
"129"	"Rivzi_2015"	"luad_mskcc_2015_2"	"WES"	"Responder"	14.7	"Lung Adenocarcinoma"	"Former"	63	"Female"	""	"Strong"	24.1333333333	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	1	1	1	1	0	1	0	0	0	NA	6	3	0
"130"	"Rivzi_2015"	"luad_mskcc_2015_16"	"WES"	"Non-Responder"	3.3	"Lung Adenocarcinoma"	"Never"	60	"Male"	""	"Negative"	6.13333333333	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"131"	"Rivzi_2015"	"luad_mskcc_2015_12"	"WES"	"Responder"	8.1	"Lung Adenocarcinoma"	"Former"	64	"Female"	""	"Strong"	9.86666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	0	0	0
"132"	"Rivzi_2015"	"luad_mskcc_2015_28"	"WES"	"Non-Responder"	3.5	"Lung Adenocarcinoma"	"Former"	62	"Female"	""	""	3.63333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"133"	"Rivzi_2015"	"luad_mskcc_2015_29"	"WES"	"Non-Responder"	6.3	"Lung Adenocarcinoma"	"Former"	56	"Female"	""	""	2.5	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"134"	"Rivzi_2015"	"luad_mskcc_2015_5"	"WES"	"Responder"	14.6	"Lung Adenocarcinoma"	"Former"	66	"Male"	""	""	13.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	1	1	0	0	0	0	NA	3	2	1
"135"	"Rivzi_2015"	"luad_mskcc_2015_13"	"WES"	"Non-Responder"	1.8	"Lung Adenocarcinoma"	"Former"	56	"Male"	""	""	9.46666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"136"	"Rivzi_2015"	"luad_mskcc_2015_32"	"WES"	"Non-Responder"	1.9	"Lung Adenocarcinoma"	"Current"	41	"Female"	""	""	1.16666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"137"	"Rivzi_2015"	"luad_mskcc_2015_25"	"WES"	"Non-Responder"	1.4	"Lung Adenocarcinoma"	"Former"	63	"Male"	""	""	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"138"	"Rivzi_2015"	"luad_mskcc_2015_20"	"WES"	"Responder"	10.4	"Lung Adenocarcinoma"	"Former"	78	"Female"	""	"Strong"	6.5	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"139"	"Rivzi_2015"	"luad_mskcc_2015_6"	"WES"	"Responder"	16.6	"Lung Adenocarcinoma"	"Former"	60	"Female"	""	"Strong"	15.6	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	6	1	0
"140"	"Rivzi_2015"	"luad_mskcc_2015_27"	"WES"	"Non-Responder"	2.1	"Lung Adenocarcinoma"	"Former"	71	"Male"	""	""	3.46666666667	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"141"	"Rivzi_2015"	"luad_mskcc_2015_1"	"WES"	"Responder"	8.4	"Lung Adenocarcinoma"	"Former"	63	"Female"	""	""	38.8	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	NA	5	1	0
"142"	"Rivzi_2015"	"luad_mskcc_2015_19"	"WES"	"Responder"	27.3	"Lung Adenocarcinoma"	"Never"	68	"Male"	""	""	6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"143"	"Rivzi_2015"	"luad_mskcc_2015_10"	"WES"	"Responder"	12.6	"Lung Adenocarcinoma"	"Current"	64	"Female"	""	""	9.73333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"144"	"Rivzi_2015"	"luad_mskcc_2015_21"	"WES"	"Responder"	8.3	"Lung Adenocarcinoma"	"Current"	59	"Male"	""	""	6.03333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"145"	"Rivzi_2015"	"luad_mskcc_2015_17"	"WES"	"Non-Responder"	3.4	"Lung Adenocarcinoma"	"Former"	51	"Female"	""	"Negative"	5.93333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"146"	"Rivzi_2015"	"luad_mskcc_2015_3"	"WES"	"Non-Responder"	2.1	"Lung Adenocarcinoma"	"Current"	66	"Male"	""	"Negative"	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	NA	1	0	1
"147"	"Rivzi_2015"	"luad_mskcc_2015_31"	"WES"	"Non-Responder"	4.1	"Lung Adenocarcinoma"	"Former"	71	"Female"	""	""	1.36666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"148"	"Rivzi_2015"	"luad_mskcc_2015_34"	"WES"	"Non-Responder"	6.3	"Lung Adenocarcinoma"	"Former"	57	"Female"	""	""	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"149"	"Rivzi_2015"	"luad_mskcc_2015_26"	"WES"	"Non-Responder"	1.9	"Lung Adenocarcinoma"	"Never"	49	"Male"	""	"Strong"	4.16666666667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"150"	"Rivzi_2015"	"luad_mskcc_2015_4"	"WES"	"Responder"	8.3	"Lung Adenocarcinoma"	"Never"	68	"Female"	""	""	16.3666666667	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	NA	3	2	1
"151"	"Rivzi_2015"	"luad_mskcc_2015_7"	"WES"	"Non-Responder"	1.9	"Lung Adenocarcinoma"	"Never"	76	"Female"	""	"Negative"	12.0333333333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"152"	"Rivzi_2018"	"P-0000012"	"IMPACT341"	"Responder"	27.2	"Lung Adenocarcinoma"	"Current/Former"	58	"Female"	""	""	32.1655037173	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	5	0	0
"153"	"Rivzi_2018"	"P-0000235"	"IMPACT341"	"Non-Responder"	0.6	"Lung Squamous Cell Carcinoma"	"Current/Former"	77	"Male"	""	""	8.87324240478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"154"	"Rivzi_2018"	"P-0000299"	"IMPACT341"	"Non-Responder"	1.63	"Large Cell Neuroendocrine Carcinoma"	"Current/Former"	66	"Male"	""	""	7.76408710418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	0	1	1
"155"	"Rivzi_2018"	"P-0000363"	"IMPACT341"	"Non-Responder"	1.2	"Lung Squamous Cell Carcinoma"	"Never"	71	"Male"	""	""	12.2007083066	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	1	0	0
"156"	"Rivzi_2018"	"P-0000563"	"IMPACT341"	"Non-Responder"	1.5	"Lung Adenocarcinoma"	"Never"	42	"Male"	""	"Negative"	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"157"	"Rivzi_2018"	"P-0000604"	"IMPACT341"	"Responder"	11.83	"Lung Adenocarcinoma"	"Never"	57	"Male"	""	"Negative"	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"158"	"Rivzi_2018"	"P-0000670"	"IMPACT341"	"Non-Responder"	2.33	"Lung Adenocarcinoma"	"Current/Former"	49	"Female"	""	""	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"159"	"Rivzi_2018"	"P-0000689"	"IMPACT410"	"Non-Responder"	2.57	"Lung Adenocarcinoma"	"Current/Former"	58	"Male"	""	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	1	0	1
"160"	"Rivzi_2018"	"P-0000826"	"IMPACT341"	"Non-Responder"	3.8	"Lung Squamous Cell Carcinoma"	"Current/Former"	64	"Male"	""	"Weak"	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	NA	0	1	0
"161"	"Rivzi_2018"	"P-0001093"	"IMPACT341"	"Responder"	22.43	"Lung Adenocarcinoma"	"Current/Former"	65	"Male"	""	"Weak"	12.2007083066	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"162"	"Rivzi_2018"	"P-0001121"	"IMPACT341"	"Non-Responder"	1.17	"Large Cell Neuroendocrine Carcinoma"	"Current/Former"	44	"Female"	""	""	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"163"	"Rivzi_2018"	"P-0001171"	"IMPACT341"	"Responder"	13.17	"Lung Adenocarcinoma"	"Current/Former"	53	"Male"	""	""	96.496511152	0	0	1	1	0	1	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	1	1	0	0	0	1	0	0	1	0	1	0	0	1	0	0	1	0	0	0	0	1	1	1	0	NA	17	2	1
"164"	"Rivzi_2018"	"P-0001340"	"IMPACT341"	"Non-Responder"	5.33	"Non-Small Cell Lung Cancer"	"Current/Former"	62	"Male"	""	"Weak"	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"165"	"Rivzi_2018"	"P-0001365"	"IMPACT341"	"Non-Responder"	1.87	"Lung Adenocarcinoma"	"Current/Former"	71	"Male"	""	""	12.2007083066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	0	0	1
"166"	"Rivzi_2018"	"P-0001385"	"IMPACT341"	"Responder"	30.43	"Lung Adenocarcinoma"	"Current/Former"	50	"Female"	""	"Strong"	14.4190189078	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	1	0	0	0	NA	3	1	1
"167"	"Rivzi_2018"	"P-0001633"	"IMPACT341"	"Non-Responder"	0.67	"Lung Adenocarcinoma"	"Never"	55	"Female"	""	"Negative"	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	0	0	1
"168"	"Rivzi_2018"	"P-0001665"	"IMPACT341"	"Non-Responder"	3.07	"Lung Adenocarcinoma"	"Never"	48	"Female"	""	""	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"169"	"Rivzi_2018"	"P-0001830"	"IMPACT341"	"Non-Responder"	4.63	"Lung Adenocarcinoma"	"Current/Former"	74	"Female"	""	""	12.2007083066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	1	0	1	1	0	0	0	NA	3	1	1
"170"	"Rivzi_2018"	"P-0001836"	"IMPACT341"	"Non-Responder"	1.77	"Lung Adenocarcinoma"	"Current/Former"	60	"Female"	""	""	23.2922613126	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	5	0	0
"171"	"Rivzi_2018"	"P-0001867"	"IMPACT341"	"Non-Responder"	4.2	"Lung Adenocarcinoma"	"Current/Former"	70	"Male"	""	""	14.4190189078	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	0	0	0
"172"	"Rivzi_2018"	"P-0001977"	"IMPACT341"	"Non-Responder"	1.3	"Lung Adenocarcinoma"	"Current/Former"	80	"Male"	""	""	9.98239770538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	0	1	0
"173"	"Rivzi_2018"	"P-0002028"	"IMPACT341"	"Responder"	25.03	"Lung Squamous Cell Carcinoma"	"Current/Former"	64	"Female"	""	""	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	NA	2	1	0
"174"	"Rivzi_2018"	"P-0002151"	"IMPACT341"	"Responder"	9.6	"Lung Adenocarcinoma"	"Current/Former"	71	"Female"	""	""	9.98239770538	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	NA	4	1	0
"175"	"Rivzi_2018"	"P-0002160"	"IMPACT341"	"Non-Responder"	1.27	"Lung Adenocarcinoma"	"Current/Former"	66	"Male"	""	""	13.3098636072	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"176"	"Rivzi_2018"	"P-0002225"	"IMPACT410"	"Non-Responder"	2.57	"Lung Squamous Cell Carcinoma"	"Never"	71	"Male"	""	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"177"	"Rivzi_2018"	"P-0002247"	"IMPACT341"	"Non-Responder"	2.77	"Lung Adenocarcinoma"	"Current/Former"	69	"Female"	""	"Weak"	21.0739507114	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"178"	"Rivzi_2018"	"P-0002252"	"IMPACT341"	"Non-Responder"	4.27	"Lung Squamous Cell Carcinoma"	"Current/Former"	73	"Female"	""	""	16.637329509	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"179"	"Rivzi_2018"	"P-0002295"	"IMPACT341"	"Non-Responder"	1.93	"Lung Adenocarcinoma"	"Never"	75	"Female"	""	"Negative"	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"180"	"Rivzi_2018"	"P-0002351"	"IMPACT341"	"Non-Responder"	5.37	"Lung Squamous Cell Carcinoma"	"Current/Former"	74	"Female"	""	""	7.76408710418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"181"	"Rivzi_2018"	"P-0002444"	"IMPACT341"	"Non-Responder"	2.1	"Lung Adenocarcinoma"	"Current/Former"	66	"Male"	""	""	16.637329509	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	2	1	1
"182"	"Rivzi_2018"	"P-0002485"	"IMPACT341"	"Responder"	7.5	"Lung Squamous Cell Carcinoma"	"Current/Former"	43	"Male"	""	"Negative"	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	NA	0	1	0
"183"	"Rivzi_2018"	"P-0002546"	"IMPACT341"	"Responder"	7.9	"Lung Adenocarcinoma"	"Current/Former"	67	"Male"	""	""	3.32746590179	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"184"	"Rivzi_2018"	"P-0002559"	"IMPACT341"	"Non-Responder"	1.07	"Lung Adenocarcinoma"	"Never"	37	"Female"	""	""	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"185"	"Rivzi_2018"	"P-0002637"	"IMPACT341"	"Responder"	27.6	"Large Cell Neuroendocrine Carcinoma"	"Current/Former"	53	"Male"	""	"Negative"	18.8556401102	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	6	0	0
"186"	"Rivzi_2018"	"P-0002639"	"IMPACT341"	"Responder"	8.1	"Lung Adenocarcinoma"	"Current/Former"	67	"Female"	""	""	12.2007083066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	3	0	0
"187"	"Rivzi_2018"	"P-0002731"	"IMPACT410"	"Responder"	15.03	"Lung Adenocarcinoma"	"Current/Former"	64	"Female"	""	""	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	1	0	1
"188"	"Rivzi_2018"	"P-0002751"	"IMPACT341"	"Non-Responder"	4.43	"Lung Adenocarcinoma"	"Current/Former"	68	"Female"	""	"Weak"	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	0	1	0
"189"	"Rivzi_2018"	"P-0002758"	"IMPACT341"	"Non-Responder"	1.8	"Non-Small Cell Lung Cancer"	"Current/Former"	62	"Male"	""	""	33.2746590179	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	3	0	1
"190"	"Rivzi_2018"	"P-0002766"	"IMPACT341"	"Non-Responder"	1.57	"Lung Adenocarcinoma"	"Current/Former"	66	"Female"	""	"Weak"	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	0	1	1
"191"	"Rivzi_2018"	"P-0002794"	"IMPACT410"	"Responder"	15.97	"Lung Adenocarcinoma"	"Current/Former"	61	"Female"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	NA	3	2	0
"192"	"Rivzi_2018"	"P-0002806"	"IMPACT341"	"Responder"	8.3	"Lung Adenocarcinoma"	"Current/Former"	80	"Male"	""	"Negative"	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	0	1	1
"193"	"Rivzi_2018"	"P-0002826"	"IMPACT341"	"Non-Responder"	1.57	"Lung Adenocarcinoma"	"Current/Former"	61	"Female"	""	""	14.4190189078	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	3	1	1
"194"	"Rivzi_2018"	"P-0002874"	"IMPACT341"	"Non-Responder"	1.03	"Lung Adenocarcinoma"	"Current/Former"	55	"Female"	""	""	14.4190189078	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	1	0	0	0	NA	4	1	0
"195"	"Rivzi_2018"	"P-0002905"	"IMPACT341"	"Non-Responder"	1.63	"Lung Adenocarcinoma"	"Current/Former"	73	"Male"	""	""	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	0	1	1
"196"	"Rivzi_2018"	"P-0002912"	"IMPACT341"	"Non-Responder"	4.33	"Lung Adenocarcinoma"	"Never"	22	"Male"	""	""	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"197"	"Rivzi_2018"	"P-0002917"	"IMPACT341"	"Non-Responder"	2.57	"Lung Adenocarcinoma"	"Current/Former"	51	"Female"	""	""	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	0	1	1
"198"	"Rivzi_2018"	"P-0002921"	"IMPACT341"	"Responder"	6.63	"Lung Adenocarcinoma"	"Current/Former"	73	"Female"	""	"Negative"	14.4190189078	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"199"	"Rivzi_2018"	"P-0002965"	"IMPACT341"	"Non-Responder"	1.17	"Lung Squamous Cell Carcinoma"	"Current/Former"	56	"Male"	""	""	7.76408710418	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	3	0	1
"200"	"Rivzi_2018"	"P-0002969"	"IMPACT341"	"Non-Responder"	0.73	"Lung Adenocarcinoma"	"Current/Former"	56	"Male"	""	""	22.183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	2	0	1
"201"	"Rivzi_2018"	"P-0003017"	"IMPACT341"	"Responder"	6.13	"Lung Adenocarcinoma"	"Never"	81	"Female"	""	"Negative"	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"202"	"Rivzi_2018"	"P-0003034"	"IMPACT410"	"Non-Responder"	3.6	"Lung Adenocarcinoma"	"Current/Former"	80	"Male"	""	""	13.7020757666	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"203"	"Rivzi_2018"	"P-0003119"	"IMPACT410"	"Non-Responder"	5.57	"Lung Adenocarcinoma"	"Current/Former"	53	"Male"	""	""	12.723356069	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	6	0	0
"204"	"Rivzi_2018"	"P-0003132"	"IMPACT410"	"Non-Responder"	1.83	"Lung Squamous Cell Carcinoma"	"Current/Former"	67	"Female"	""	"Strong"	34.2551894165	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"205"	"Rivzi_2018"	"P-0003157"	"IMPACT410"	"Non-Responder"	0.77	"Lung Squamous Cell Carcinoma"	"Never"	63	"Male"	""	""	5.87231818569	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"206"	"Rivzi_2018"	"P-0003229"	"IMPACT410"	"Responder"	19.77	"Lung Adenocarcinoma"	"Current/Former"	60	"Male"	""	"Weak"	47.9572651831	0	0	0	1	0	1	0	1	0	0	1	0	0	1	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	NA	12	1	0
"207"	"Rivzi_2018"	"P-0003275"	"IMPACT410"	"Non-Responder"	5.53	"Lung Adenocarcinoma"	"Current/Former"	69	"Male"	""	"Negative"	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"208"	"Rivzi_2018"	"P-0003347"	"IMPACT410"	"Responder"	6.17	"Lung Squamous Cell Carcinoma"	"Current/Former"	58	"Male"	""	"Weak"	14.6807954642	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	0	0	0
"209"	"Rivzi_2018"	"P-0003368"	"IMPACT410"	"Responder"	30.47	"Lung Adenocarcinoma"	"Current/Former"	57	"Female"	""	"Strong"	8.80847727853	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	1	0	0	0	NA	4	2	0
"210"	"Rivzi_2018"	"P-0003562"	"IMPACT410"	"Responder"	9.2	"Lung Adenocarcinoma"	"Current/Former"	60	"Female"	""	""	36.2126288117	0	0	1	0	0	0	0	1	1	0	0	1	0	0	1	0	0	0	1	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	10	0	0
"211"	"Rivzi_2018"	"P-0003584"	"IMPACT410"	"Responder"	8.33	"Lung Adenocarcinoma"	"Current/Former"	59	"Male"	""	"Weak"	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	3	1	0
"212"	"Rivzi_2018"	"P-0003738"	"IMPACT410"	"Responder"	10.4	"Lung Adenocarcinoma"	"Never"	57	"Female"	""	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"213"	"Rivzi_2018"	"P-0003782"	"IMPACT410"	"Non-Responder"	3.1	"Lung Adenocarcinoma"	"Current/Former"	58	"Male"	""	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"214"	"Rivzi_2018"	"P-0003869"	"IMPACT410"	"Non-Responder"	5.47	"Lung Adenocarcinoma"	"Current/Former"	66	"Female"	""	"Negative"	54.8083030664	0	0	0	1	1	0	0	1	0	0	1	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	1	0	0	1	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	1	0	1	1	1	0	0	NA	16	3	1
"215"	"Rivzi_2018"	"P-0003964"	"IMPACT341"	"Non-Responder"	2.8	"Lung Adenocarcinoma"	"Current/Former"	73	"Male"	""	"Weak"	9.98239770538	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	NA	2	2	0
"216"	"Rivzi_2018"	"P-0004020"	"IMPACT410"	"Non-Responder"	5.13	"Lung Adenocarcinoma"	"Current/Former"	58	"Female"	""	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"217"	"Rivzi_2018"	"P-0004054"	"IMPACT410"	"Non-Responder"	3.17	"Lung Adenocarcinoma"	"Current/Former"	61	"Male"	""	""	13.7020757666	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	3	0	1
"218"	"Rivzi_2018"	"P-0004436"	"IMPACT410"	"Non-Responder"	1.83	"Lung Adenocarcinoma"	"Current/Former"	75	"Male"	""	""	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	1	0	1
"219"	"Rivzi_2018"	"P-0004442"	"IMPACT410"	"Non-Responder"	3.3	"Lung Adenocarcinoma"	"Current/Former"	62	"Male"	""	""	34.2551894165	0	1	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	1	0	1	0	NA	9	0	2
"220"	"Rivzi_2018"	"P-0004463"	"IMPACT410"	"Non-Responder"	1.57	"Lung Adenocarcinoma"	"Never"	82	"Male"	""	""	6.8510378833	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"221"	"Rivzi_2018"	"P-0004472"	"IMPACT410"	"Non-Responder"	4	"Lung Adenocarcinoma"	"Current/Former"	62	"Female"	""	""	13.7020757666	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	NA	2	1	0
"222"	"Rivzi_2018"	"P-0004495"	"IMPACT410"	"Non-Responder"	1.07	"Lung Squamous Cell Carcinoma"	"Current/Former"	40	"Male"	""	""	8.80847727853	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	NA	4	0	0
"223"	"Rivzi_2018"	"P-0004517"	"IMPACT410"	"Non-Responder"	1.67	"Lung Squamous Cell Carcinoma"	"Never"	67	"Male"	""	"Negative"	13.7020757666	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"224"	"Rivzi_2018"	"P-0004588"	"IMPACT410"	"Responder"	20.2	"Lung Adenocarcinoma"	"Current/Former"	73	"Male"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	1	1	0
"225"	"Rivzi_2018"	"P-0004701"	"IMPACT410"	"Responder"	20	"Non-Small Cell Lung Cancer"	"Current/Former"	52	"Female"	""	""	19.5743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1	1	0	0	0	NA	4	0	1
"226"	"Rivzi_2018"	"P-0004759"	"IMPACT410"	"Non-Responder"	0.67	"Lung Adenocarcinoma"	"Current/Former"	63	"Female"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	NA	0	0	1
"227"	"Rivzi_2018"	"P-0004827"	"IMPACT410"	"Responder"	10.47	"Lung Squamous Cell Carcinoma"	"Current/Former"	58	"Male"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"228"	"Rivzi_2018"	"P-0004890"	"IMPACT410"	"Non-Responder"	1.83	"Lung Adenocarcinoma"	"Current/Former"	69	"Female"	""	""	10.7659166738	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	4	1	1
"229"	"Rivzi_2018"	"P-0004996"	"IMPACT410"	"Non-Responder"	1.83	"Lung Squamous Cell Carcinoma"	"Never"	54	"Male"	""	"Strong"	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"230"	"Rivzi_2018"	"P-0005048"	"IMPACT410"	"Responder"	15.07	"Lung Adenocarcinoma"	"Never"	68	"Female"	""	"Strong"	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"231"	"Rivzi_2018"	"P-0005115"	"IMPACT410"	"Non-Responder"	1.83	"Lung Squamous Cell Carcinoma"	"Current/Former"	55	"Male"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"232"	"Rivzi_2018"	"P-0005289"	"IMPACT410"	"Non-Responder"	1.23	"Lung Adenocarcinoma"	"Current/Former"	67	"Male"	""	""	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"233"	"Rivzi_2018"	"P-0005295"	"IMPACT410"	"Responder"	16.9	"Lung Adenocarcinoma"	"Current/Former"	73	"Male"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	NA	1	0	0
"234"	"Rivzi_2018"	"P-0005320"	"IMPACT410"	"Responder"	6.57	"Lung Adenocarcinoma"	"Current/Former"	47	"Male"	""	""	7.82975758092	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"235"	"Rivzi_2018"	"P-0005510"	"IMPACT410"	"Responder"	21.13	"Lung Adenocarcinoma"	"Current/Former"	67	"Male"	""	"Weak"	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	0	1	1
"236"	"Rivzi_2018"	"P-0005629"	"IMPACT410"	"Non-Responder"	1.73	"Lung Adenocarcinoma"	"Current/Former"	81	"Female"	""	""	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	1	1	1
"237"	"Rivzi_2018"	"P-0005721"	"IMPACT410"	"Responder"	10.43	"Lung Adenocarcinoma"	"Current/Former"	79	"Male"	""	""	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	0	0	1
"238"	"Rivzi_2018"	"P-0005792"	"IMPACT410"	"Non-Responder"	3.23	"Lung Squamous Cell Carcinoma"	"Current/Former"	59	"Male"	""	""	10.7659166738	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"239"	"Rivzi_2018"	"P-0005848"	"IMPACT410"	"Responder"	8.63	"Lung Adenocarcinoma"	"Current/Former"	81	"Female"	""	""	16.6382348595	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	5	1	1
"240"	"Rivzi_2018"	"P-0005898"	"IMPACT410"	"Responder"	12.53	"Lung Squamous Cell Carcinoma"	"Never"	71	"Female"	""	""	3.91487879046	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"241"	"Rivzi_2018"	"P-0005975"	"IMPACT410"	"Non-Responder"	1.17	"Lung Adenocarcinoma"	"Current/Former"	81	"Female"	""	"Negative"	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	1	1	1
"242"	"Rivzi_2018"	"P-0005981"	"IMPACT410"	"Responder"	18.9	"Lung Adenocarcinoma"	"Current/Former"	60	"Male"	""	"Strong"	9.78719697615	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	3	1	0
"243"	"Rivzi_2018"	"P-0006047"	"IMPACT410"	"Responder"	7.8	"Lung Adenocarcinoma"	"Never"	62	"Female"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"244"	"Rivzi_2018"	"P-0006071"	"IMPACT410"	"Non-Responder"	4.73	"Lung Adenocarcinoma"	"Current/Former"	53	"Female"	""	"Negative"	17.6169545571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	4	0	1
"245"	"Rivzi_2018"	"P-0006084"	"IMPACT410"	"Non-Responder"	3.5	"Lung Adenocarcinoma"	"Never"	62	"Male"	""	"Negative"	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	0	0	1
"246"	"Rivzi_2018"	"P-0006294"	"IMPACT410"	"Non-Responder"	0.73	"Lung Adenocarcinoma"	"Current/Former"	63	"Female"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"247"	"Rivzi_2018"	"P-0006312"	"IMPACT410"	"Responder"	15.3	"Lung Adenocarcinoma"	"Never"	51	"Female"	""	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"248"	"Rivzi_2018"	"P-0006330"	"IMPACT410"	"Non-Responder"	5.4	"Lung Adenocarcinoma"	"Never"	45	"Male"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"249"	"Rivzi_2018"	"P-0006343"	"IMPACT410"	"Non-Responder"	1.6	"Lung Adenocarcinoma"	"Current/Former"	60	"Female"	""	"Strong"	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"250"	"Rivzi_2018"	"P-0006364"	"IMPACT410"	"Non-Responder"	4.33	"Lung Adenocarcinoma"	"Current/Former"	63	"Male"	""	"Weak"	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	1	1	0
"251"	"Rivzi_2018"	"P-0006415"	"IMPACT410"	"Non-Responder"	1.97	"Lung Adenocarcinoma"	"Current/Former"	86	"Male"	""	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1	NA	2	2	0
"252"	"Rivzi_2018"	"P-0006540"	"IMPACT410"	"Non-Responder"	1.67	"Lung Squamous Cell Carcinoma"	"Current/Former"	70	"Male"	""	""	11.7446363714	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	NA	2	1	0
"253"	"Rivzi_2018"	"P-0006642"	"IMPACT410"	"Non-Responder"	2.7	"Lung Adenocarcinoma"	"Current/Former"	68	"Female"	""	""	20.5531136499	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	5	0	0
"254"	"Rivzi_2018"	"P-0006724"	"IMPACT410"	"Responder"	7.37	"Non-Small Cell Lung Cancer"	"Current/Former"	48	"Female"	""	""	23.4892727428	0	0	1	0	1	1	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	NA	12	1	0
"255"	"Rivzi_2018"	"P-0006768"	"IMPACT410"	"Non-Responder"	4.27	"Lung Adenocarcinoma"	"Current/Former"	66	"Male"	""	"Negative"	12.723356069	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	NA	3	0	2
"256"	"Rivzi_2018"	"P-0006895"	"IMPACT410"	"Responder"	9.37	"Lung Adenocarcinoma"	"Current/Former"	65	"Male"	""	""	36.2126288117	0	0	1	0	0	1	1	0	0	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	1	0	1	0	0	0	1	0	0	0	NA	14	0	0
"257"	"Rivzi_2018"	"P-0006954"	"IMPACT410"	"Non-Responder"	1.63	"Lung Adenocarcinoma"	"Current/Former"	66	"Female"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	NA	1	0	1
"258"	"Rivzi_2018"	"P-0006993"	"IMPACT410"	"Non-Responder"	1	"Lung Adenocarcinoma"	"Current/Former"	68	"Male"	""	"Negative"	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	1	1	1
"259"	"Rivzi_2018"	"P-0007084"	"IMPACT410"	"Non-Responder"	1.63	"Lung Adenocarcinoma"	"Current/Former"	83	"Male"	""	"Weak"	8.80847727853	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0	1	0	NA	2	2	1
"260"	"Rivzi_2018"	"P-0007101"	"IMPACT410"	"Non-Responder"	1.7	"Lung Adenocarcinoma"	"Current/Former"	76	"Male"	""	""	11.7446363714	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	1	0	0	0	NA	2	1	1
"261"	"Rivzi_2018"	"P-0007121"	"IMPACT410"	"Responder"	8.77	"Lung Adenocarcinoma"	"Current/Former"	58	"Female"	""	"Weak"	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	1	0	0	0	NA	1	1	0
"262"	"Rivzi_2018"	"P-0007123"	"IMPACT410"	"Responder"	15.9	"Lung Adenocarcinoma"	"Current/Former"	66	"Female"	""	""	8.80847727853	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	1	1	1
"263"	"Rivzi_2018"	"P-0007278"	"IMPACT410"	"Non-Responder"	2.57	"Large Cell Neuroendocrine Carcinoma"	"Current/Former"	55	"Female"	""	"Negative"	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	1	1	1
"264"	"Rivzi_2018"	"P-0007418"	"IMPACT410"	"Responder"	12.87	"Lung Adenocarcinoma"	"Current/Former"	56	"Female"	""	""	16.6382348595	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"265"	"Rivzi_2018"	"P-0007420"	"IMPACT410"	"Non-Responder"	2.37	"Lung Adenocarcinoma"	"Current/Former"	85	"Female"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"266"	"Rivzi_2018"	"P-0007583"	"IMPACT410"	"Non-Responder"	1.63	"Lung Adenocarcinoma"	"Current/Former"	69	"Female"	""	"Strong"	13.7020757666	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	NA	2	2	0
"267"	"Rivzi_2018"	"P-0007597"	"IMPACT410"	"Non-Responder"	1.17	"Lung Adenocarcinoma"	"Current/Former"	73	"Male"	""	""	15.6595151618	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	2	1	0
"268"	"Rivzi_2018"	"P-0007619"	"IMPACT410"	"Non-Responder"	1.17	"Lung Adenocarcinoma"	"Current/Former"	77	"Male"	""	""	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	1	0	0	0	NA	1	0	1
"269"	"Rivzi_2018"	"P-0007633"	"IMPACT410"	"Responder"	24.27	"Lung Adenocarcinoma"	"Never"	76	"Male"	""	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"270"	"Rivzi_2018"	"P-0007757"	"IMPACT410"	"Responder"	6.33	"Non-Small Cell Lung Cancer"	"Current/Former"	37	"Female"	""	""	8.80847727853	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	1	1	0
"271"	"Rivzi_2018"	"P-0007861"	"IMPACT410"	"Non-Responder"	2.6	"Lung Adenocarcinoma"	"Never"	76	"Female"	""	"Weak"	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"272"	"Rivzi_2018"	"P-0007879"	"IMPACT410"	"Responder"	12.07	"Lung Adenocarcinoma"	"Current/Former"	68	"Female"	""	"Strong"	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"273"	"Rivzi_2018"	"P-0007978"	"IMPACT410"	"Non-Responder"	2.5	"Lung Adenocarcinoma"	"Current/Former"	50	"Female"	""	""	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	2	0	1
"274"	"Rivzi_2018"	"P-0008176"	"IMPACT410"	"Non-Responder"	1.93	"Lung Adenocarcinoma"	"Never"	71	"Female"	""	"Negative"	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	1	1	0
"275"	"Rivzi_2018"	"P-0008239"	"IMPACT410"	"Responder"	15.13	"Lung Squamous Cell Carcinoma"	"Current/Former"	74	"Female"	""	""	15.6595151618	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	NA	2	1	0
"276"	"Rivzi_2018"	"P-0008295"	"IMPACT410"	"Non-Responder"	3.17	"Lung Adenocarcinoma"	"Current/Former"	57	"Male"	""	"Negative"	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	2	0	0
"277"	"Rivzi_2018"	"P-0008370"	"IMPACT410"	"Non-Responder"	0.9	"Lung Adenocarcinoma"	"Current/Former"	77	"Female"	""	""	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"278"	"Rivzi_2018"	"P-0008406"	"IMPACT410"	"Non-Responder"	1.17	"Lung Adenocarcinoma"	"Current/Former"	67	"Female"	""	""	24.4679924404	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	6	0	0
"279"	"Rivzi_2018"	"P-0008715"	"IMPACT410"	"Responder"	9.1	"Lung Adenocarcinoma"	"Current/Former"	73	"Male"	""	""	18.5956742547	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	NA	4	0	1
"280"	"Rivzi_2018"	"P-0008848"	"IMPACT410"	"Non-Responder"	1.33	"Large Cell Neuroendocrine Carcinoma"	"Current/Former"	76	"Male"	""	""	5.87231818569	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	1	1	0
"281"	"Rivzi_2018"	"P-0008851"	"IMPACT410"	"Non-Responder"	1.4	"Non-Small Cell Lung Cancer"	"Current/Former"	63	"Male"	""	"Weak"	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	NA	0	1	0
"282"	"Rivzi_2018"	"P-0008935"	"IMPACT410"	"Non-Responder"	3.07	"Lung Adenocarcinoma"	"Current/Former"	74	"Female"	""	""	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"283"	"Rivzi_2018"	"P-0008944"	"IMPACT410"	"Non-Responder"	1.6	"Lung Adenocarcinoma"	"Current/Former"	46	"Female"	""	"Strong"	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	3	0	0
"284"	"Rivzi_2018"	"P-0008976"	"IMPACT410"	"Responder"	22.63	"Lung Adenocarcinoma"	"Current/Former"	83	"Male"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	NA	0	0	1
"285"	"Rivzi_2018"	"P-0009080"	"IMPACT410"	"Non-Responder"	1.87	"Lung Squamous Cell Carcinoma"	"Current/Former"	74	"Male"	""	"Negative"	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"286"	"Rivzi_2018"	"P-0009256"	"IMPACT410"	"Responder"	7.47	"Lung Adenocarcinoma"	"Current/Former"	75	"Female"	""	"Negative"	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	4	1	1
"287"	"Rivzi_2018"	"P-0009274"	"IMPACT410"	"Non-Responder"	1	"Lung Adenocarcinoma"	"Current/Former"	76	"Female"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"288"	"Rivzi_2018"	"P-0009293"	"IMPACT410"	"Responder"	16.57	"Lung Adenocarcinoma"	"Current/Former"	80	"Female"	""	"Negative"	21.5318333475	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	4	0	0
"289"	"Rivzi_2018"	"P-0009319"	"IMPACT410"	"Responder"	13	"Lung Adenocarcinoma"	"Current/Former"	62	"Male"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"290"	"Rivzi_2018"	"P-0009379"	"IMPACT410"	"Non-Responder"	1.03	"Lung Adenocarcinoma"	"Current/Former"	69	"Male"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	0	1	1
"291"	"Rivzi_2018"	"P-0009419"	"IMPACT410"	"Non-Responder"	1.73	"Lung Adenocarcinoma"	"Current/Former"	60	"Male"	""	""	11.7446363714	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	NA	2	0	0
"292"	"Rivzi_2018"	"P-0009426"	"IMPACT410"	"Non-Responder"	5.53	"Lung Adenocarcinoma"	"Current/Former"	64	"Female"	""	""	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	0	1	1
"293"	"Rivzi_2018"	"P-0009469"	"IMPACT410"	"Non-Responder"	2.73	"Lung Adenocarcinoma"	"Never"	32	"Female"	""	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"294"	"Rivzi_2018"	"P-0009473"	"IMPACT410"	"Responder"	11.97	"Lung Adenocarcinoma"	"Current/Former"	79	"Male"	""	""	7.82975758092	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	3	1	0
"295"	"Rivzi_2018"	"P-0009501"	"IMPACT410"	"Non-Responder"	2.6	"Lung Squamous Cell Carcinoma"	"Current/Former"	72	"Male"	""	""	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"296"	"Rivzi_2018"	"P-0009505"	"IMPACT410"	"Non-Responder"	2.2	"Lung Adenocarcinoma"	"Current/Former"	62	"Female"	""	""	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	1	1	1
"297"	"Rivzi_2018"	"P-0009521"	"IMPACT410"	"Non-Responder"	2.47	"Non-Small Cell Lung Cancer"	"Current/Former"	74	"Female"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"298"	"Rivzi_2018"	"P-0009586"	"IMPACT410"	"Responder"	7.17	"Lung Adenocarcinoma"	"Current/Former"	55	"Female"	""	""	11.7446363714	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	5	1	0
"299"	"Rivzi_2018"	"P-0009763"	"IMPACT410"	"Non-Responder"	1.57	"Lung Adenocarcinoma"	"Current/Former"	48	"Female"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"300"	"Rivzi_2018"	"P-0009764"	"IMPACT410"	"Responder"	6.3	"Lung Adenocarcinoma"	"Current/Former"	50	"Female"	""	""	22.5105530451	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	NA	7	0	0
"301"	"Rivzi_2018"	"P-0009833"	"IMPACT410"	"Responder"	10.4	"Lung Adenocarcinoma"	"Current/Former"	54	"Female"	""	"Negative"	32.2977500213	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	1	0	0	0	NA	8	0	0
"302"	"Rivzi_2018"	"P-0009959"	"IMPACT410"	"Non-Responder"	5.87	"Lung Adenocarcinoma"	"Current/Former"	66	"Male"	""	"Negative"	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	0	1	1
"303"	"Rivzi_2018"	"P-0010024"	"IMPACT410"	"Responder"	16.73	"Lung Squamous Cell Carcinoma"	"Current/Former"	80	"Male"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	0	0	0
"304"	"Rivzi_2018"	"P-0010025"	"IMPACT410"	"Non-Responder"	1.63	"Lung Adenocarcinoma"	"Current/Former"	58	"Female"	""	""	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"305"	"Rivzi_2018"	"P-0010065"	"IMPACT410"	"Responder"	7.53	"Lung Adenocarcinoma"	"Current/Former"	39	"Male"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"306"	"Rivzi_2018"	"P-0010213"	"IMPACT410"	"Responder"	16.8	"Lung Adenocarcinoma"	"Current/Former"	50	"Female"	""	""	15.6595151618	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	1	0	0	0	NA	5	1	0
"307"	"Rivzi_2018"	"P-0010256"	"IMPACT410"	"Non-Responder"	3.1	"Lung Adenocarcinoma"	"Current/Former"	72	"Female"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	1	1	1
"308"	"Rivzi_2018"	"P-0010636"	"IMPACT410"	"Non-Responder"	5.77	"Lung Squamous Cell Carcinoma"	"Current/Former"	68	"Male"	""	"Strong"	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	1	1	0
"309"	"Rivzi_2018"	"P-0010648"	"IMPACT410"	"Non-Responder"	2.03	"Lung Adenocarcinoma"	"Current/Former"	73	"Male"	""	"Negative"	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	NA	0	1	1
"310"	"Rivzi_2018"	"P-0010736"	"IMPACT410"	"Responder"	9.8	"Lung Adenocarcinoma"	"Current/Former"	78	"Male"	""	""	25.446712138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	1	0	0	NA	5	1	0
"311"	"Rivzi_2018"	"P-0010760"	"IMPACT410"	"Non-Responder"	5.43	"Lung Adenocarcinoma"	"Current/Former"	51	"Male"	""	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"312"	"Rivzi_2018"	"P-0010840"	"IMPACT410"	"Non-Responder"	0.83	"Lung Adenocarcinoma"	"Current/Former"	55	"Female"	""	"Negative"	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	1	1	1
"313"	"Rivzi_2018"	"P-0010891"	"IMPACT410"	"Non-Responder"	1.27	"Lung Adenocarcinoma"	"Never"	42	"Female"	""	"Negative"	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"314"	"Rivzi_2018"	"P-0010986"	"IMPACT410"	"Non-Responder"	2.3	"Lung Adenocarcinoma"	"Current/Former"	55	"Female"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	0	1	0
"315"	"Rivzi_2018"	"P-0011033"	"IMPACT410"	"Non-Responder"	1.7	"Lung Adenocarcinoma"	"Never"	62	"Female"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"316"	"Rivzi_2018"	"P-0011036"	"IMPACT410"	"Non-Responder"	1.8	"Large Cell Neuroendocrine Carcinoma"	"Current/Former"	55	"Male"	""	""	11.7446363714	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	2	1	0
"317"	"Rivzi_2018"	"P-0011149"	"IMPACT410"	"Non-Responder"	2.47	"Lung Adenocarcinoma"	"Current/Former"	58	"Female"	""	"Negative"	11.7446363714	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	1	0	NA	3	1	2
"318"	"Rivzi_2018"	"P-0011180"	"IMPACT410"	"Non-Responder"	1.83	"Lung Adenocarcinoma"	"Never"	60	"Female"	""	""	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"319"	"Rivzi_2018"	"P-0011192"	"IMPACT410"	"Non-Responder"	2.27	"Lung Adenocarcinoma"	"Current/Former"	74	"Female"	""	""	10.7659166738	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"320"	"Rivzi_2018"	"P-0011244"	"IMPACT410"	"Non-Responder"	2.1	"Lung Squamous Cell Carcinoma"	"Current/Former"	76	"Male"	""	""	2.93615909284	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"321"	"Rivzi_2018"	"P-0011254"	"IMPACT410"	"Non-Responder"	1.53	"Lung Adenocarcinoma"	"Current/Former"	56	"Female"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	1	1	0
"322"	"Rivzi_2018"	"P-0011499"	"IMPACT410"	"Non-Responder"	2.27	"Lung Adenocarcinoma"	"Current/Former"	71	"Female"	""	""	7.82975758092	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	NA	2	1	1
"323"	"Rivzi_2018"	"P-0011559"	"IMPACT410"	"Non-Responder"	5.37	"Lung Adenocarcinoma"	"Current/Former"	72	"Male"	""	""	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"324"	"Rivzi_2018"	"P-0012076"	"IMPACT410"	"Non-Responder"	3.5	"Lung Adenocarcinoma"	"Never"	72	"Male"	""	""	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"325"	"Rivzi_2018"	"P-0012192"	"IMPACT410"	"Responder"	12.8	"Lung Adenocarcinoma"	"Current/Former"	72	"Female"	""	""	13.7020757666	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	3	1	0
"326"	"Rivzi_2018"	"P-0012373"	"IMPACT410"	"Non-Responder"	1.77	"Lung Adenocarcinoma"	"Current/Former"	68	"Male"	""	""	39.1487879046	0	1	0	0	0	0	0	0	1	0	0	1	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	1	0	0	0	NA	10	0	1
"327"	"Rivzi_2018"	"P-0012427"	"IMPACT410"	"Non-Responder"	1.7	"Lung Adenocarcinoma"	"Current/Former"	66	"Male"	""	""	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"328"	"Rivzi_2018"	"P-0012629"	"IMPACT410"	"Non-Responder"	4.8	"Non-Small Cell Lung Cancer"	"Current/Former"	81	"Male"	""	"Strong"	2.93615909284	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"329"	"Rivzi_2018"	"P-0012729"	"IMPACT410"	"Non-Responder"	4.27	"Lung Adenocarcinoma"	"Current/Former"	69	"Male"	""	""	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	NA	1	1	0
"330"	"Rivzi_2018"	"P-0012817"	"IMPACT410"	"Responder"	7.2	"Lung Adenocarcinoma"	"Current/Former"	54	"Male"	""	""	32.2977500213	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	NA	7	0	1
"331"	"Rivzi_2018"	"P-0012846"	"IMPACT410"	"Responder"	11.3	"Lung Adenocarcinoma"	"Current/Former"	59	"Female"	""	""	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	3	1	0
"332"	"Rivzi_2018"	"P-0012849"	"IMPACT410"	"Non-Responder"	1.7	"Lung Adenocarcinoma"	"Current/Former"	57	"Male"	""	"Weak"	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	1	1	0
"333"	"Rivzi_2018"	"P-0012866"	"IMPACT410"	"Non-Responder"	2.9	"Lung Adenocarcinoma"	"Never"	50	"Female"	""	""	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"334"	"Rivzi_2018"	"P-0012908"	"IMPACT410"	"Non-Responder"	3.6	"Lung Adenocarcinoma"	"Never"	79	"Male"	""	""	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	1	0	0
"335"	"Rivzi_2018"	"P-0012931"	"IMPACT410"	"Non-Responder"	2	"Lung Squamous Cell Carcinoma"	"Current/Former"	71	"Male"	""	""	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	NA	3	1	0
"336"	"Rivzi_2018"	"P-0013653"	"IMPACT410"	"Non-Responder"	5.43	"Lung Adenocarcinoma"	"Current/Former"	69	"Female"	""	"Negative"	7.82975758092	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"337"	"Rivzi_2018"	"P-0014172"	"IMPACT410"	"Non-Responder"	3.77	"Lung Adenocarcinoma"	"Current/Former"	83	"Male"	""	"Weak"	17.6169545571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	3	1	0
"338"	"Rivzi_2018"	"P-0014269"	"IMPACT468"	"Non-Responder"	1.7	"Lung Squamous Cell Carcinoma"	"Current/Former"	74	"Male"	""	""	0.864698094984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"339"	"Rivzi_2018"	"P-0014451"	"IMPACT468"	"Non-Responder"	0.6	"Lung Adenocarcinoma"	"Current/Former"	64	"Female"	""	"Negative"	9.51167904482	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"340"	"Rivzi_2018"	"P-0014599"	"IMPACT468"	"Responder"	8.83	"Lung Squamous Cell Carcinoma"	"Current/Former"	63	"Male"	""	""	14.6998676147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	1	0	0	0	1	0	0	0	NA	5	0	0
"341"	"Rivzi_2018"	"P-0014786"	"IMPACT468"	"Non-Responder"	1.87	"Non-Small Cell Lung Cancer"	"Current/Former"	65	"Female"	""	""	11.2410752348	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	0	NA	2	0	0
"342"	"Rivzi_2018"	"P-0014818"	"IMPACT468"	"Responder"	6.03	"Lung Adenocarcinoma"	"Current/Former"	83	"Male"	""	""	28.5350371345	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	2	0	1
"343"	"Rivzi_2018"	"P-0015078"	"IMPACT468"	"Non-Responder"	2.37	"Lung Adenocarcinoma"	"Current/Former"	69	"Female"	""	"Negative"	7.78228285485	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	NA	1	1	0
"344"	"Rivzi_2018"	"P-0015296"	"IMPACT468"	"Responder"	6.43	"Non-Small Cell Lung Cancer"	"Current/Former"	67	"Male"	""	"Strong"	19.8880561846	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	NA	4	0	0
"345"	"Rivzi_2018"	"P-0015531"	"IMPACT468"	"Responder"	7.1	"Lung Squamous Cell Carcinoma"	"Current/Former"	53	"Female"	""	""	4.32349047492	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"346"	"Rivzi_2018"	"P-0015556"	"IMPACT468"	"Responder"	16.73	"Lung Adenocarcinoma"	"Current/Former"	64	"Male"	""	""	4.32349047492	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	NA	0	1	0
"347"	"Rivzi_2018"	"P-0015771"	"IMPACT468"	"Non-Responder"	3.43	"Lung Adenocarcinoma"	"Current/Former"	62	"Male"	""	""	1.72939618997	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	0	1	0
"348"	"Rivzi_2018"	"P-0015780"	"IMPACT468"	"Non-Responder"	1.83	"Lung Adenocarcinoma"	"Current/Former"	51	"Male"	""	"Negative"	6.05288666489	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	NA	2	1	1
"349"	"Rivzi_2018"	"P-0015785"	"IMPACT468"	"Non-Responder"	4.17	"Lung Adenocarcinoma"	"Current/Former"	56	"Female"	""	""	22.4821504696	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	NA	5	1	0
"350"	"Rivzi_2018"	"P-0015984"	"IMPACT468"	"Non-Responder"	1.63	"Lung Squamous Cell Carcinoma"	"Current/Former"	66	"Female"	""	"Weak"	24.2115466595	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	NA	6	1	0
"351"	"Rivzi_2018"	"P-0016046"	"IMPACT468"	"Non-Responder"	2.67	"Lung Adenocarcinoma"	"Never"	68	"Female"	""	""	5.1881885699	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"352"	"Rivzi_2018"	"P-0016646"	"IMPACT468"	"Non-Responder"	1.87	"Lung Adenocarcinoma"	"Current/Former"	76	"Male"	""	"Negative"	9.51167904482	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	NA	2	0	1
"1100"	"BioLung_2022"	"BL_001"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	"Current"	82	"Male"	NA	"Negative"	29.14	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	3.53	5	0	0
"2100"	"BioLung_2022"	"BL_002"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Non-Small Cell Lung Cancer"	"Former"	71	"Male"	NA	"Weak"	14.23	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	7.47	6	1	0
"353"	"BioLung_2022"	"BL_005"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Squamous Cell Carcinoma"	"Former"	55	"Male"	NA	"Weak"	0.68	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	5.15	0	0	0
"410"	"BioLung_2022"	"BL_006"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Squamous Cell Carcinoma"	"Former"	78	"Female"	NA	"Strong"	3.73	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	11.93	0	1	0
"510"	"BioLung_2022"	"BL_008"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Squamous Cell Carcinoma"	"Former"	66	"Male"	NA	"Weak"	14.93	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1.57	1	0	0
"610"	"BioLung_2022"	"BL_009"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	68	"Female"	NA	"Strong"	2.37	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	2.03	0	1	0
"710"	"BioLung_2022"	"BL_014"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	65	"Female"	NA	"Weak"	12.88	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	3.92	8	0	0
"810"	"BioLung_2022"	"BL_015"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Current"	69	"Male"	NA	"Strong"	9.15	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	9.2	0	1	0
"910"	"BioLung_2022"	"BL_016"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	74	"Female"	NA	"Strong"	22.03	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	16.56	0	1	0
"1010"	"BioLung_2022"	"BL_017"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	71	"Female"	NA	NA	12.54	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.18	0	0	0
"1110"	"BioLung_2022"	"BL_019"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	65	"Female"	NA	"Strong"	3.05	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0.44	2	2	0
"1210"	"BioLung_2022"	"BL_021"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Squamous Cell Carcinoma"	"Current"	74	"Male"	NA	"Weak"	62.35	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	21.73	1	1	0
"1310"	"BioLung_2022"	"BL_025"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	"Current"	79	"Male"	NA	"Strong"	6.1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	3.38	3	1	0
"1410"	"BioLung_2022"	"BL_026"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	61	"Female"	NA	"Weak"	3.73	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1.19	4	0	0
"1510"	"BioLung_2022"	"BL_027"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Squamous Cell Carcinoma"	"Former"	70	"Male"	NA	"Strong"	6.1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	7.29	1	0	0
"1610"	"BioLung_2022"	"BL_028"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Squamous Cell Carcinoma"	"Former"	75	"Female"	NA	"Weak"	11.52	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	11.85	0	0	0
"1710"	"BioLung_2022"	"BL_029"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	76	"Male"	NA	"Weak"	4.74	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	1	0	0	0	7.83	3	0	1
"1810"	"BioLung_2022"	"BL_030"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Squamous Cell Carcinoma"	"Former"	76	"Male"	NA	"Weak"	8.81	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	18.09	0	0	0
"1910"	"BioLung_2022"	"BL_032"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Non-Small Cell Lung Cancer"	"Current"	61	"Male"	NA	"Weak"	8.13	1	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	1	0	1.26	5	0	1
"2010"	"BioLung_2022"	"BL_033"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Non-Small Cell Lung Cancer"	"Former"	73	"Female"	NA	"Strong"	18.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.08	1	0	0
"2110"	"BioLung_2022"	"BL_034"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	67	"Female"	NA	"Strong"	7.45	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	14.35	0	1	0
"2210"	"BioLung_2022"	"BL_036"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	75	"Female"	NA	"Strong"	22.36	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	21.23	1	1	0
"2310"	"BioLung_2022"	"BL_038"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Female"	NA	"Strong"	2.37	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	5.29	1	1	0
"2410"	"BioLung_2022"	"BL_042"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	NA	75	NA	NA	"Negative"	34.9	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	1	0	0	1	20.07	5	2	0
"2510"	"BioLung_2022"	"BL_043"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Squamous Cell Carcinoma"	NA	77	NA	NA	"Strong"	10.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	22.6	4	0	0
"2610"	"BioLung_2022"	"BL_045"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	NA	65	NA	NA	"Strong"	8.13	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	21.25	5	0	0
"2710"	"BioLung_2022"	"BL_046"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	NA	76	NA	NA	"Weak"	3.05	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	3.07	1	1	1
"2810"	"BioLung_2022"	"BL_047"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	"Non-Small Cell Lung Cancer"	NA	80	NA	NA	"Strong"	1.36	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2.1	2	0	0
"2910"	"BioLung_2022"	"BL_048"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Squamous Cell Carcinoma"	NA	70	NA	NA	"Strong"	22.03	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	1	1	0	0	1	1	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	5.54	12	0	0
"3010"	"BioLung_2022"	"BL_101"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	NA	NA	NA	NA	NA	NA	15.59	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	7.22	0	0	0
"3110"	"BioLung_2022"	"BL_102"	"Oncopanel_GATCLiquid"	"Responder"	NA	NA	NA	NA	NA	NA	NA	1.36	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.39	0	0	0
"3210"	"BioLung_2022"	"BL_104"	"Oncopanel_GATCLiquid"	"Responder"	NA	NA	NA	74	NA	NA	NA	9.49	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	8.13	1	1	0
"3310"	"BioLung_2022"	"BL_109"	"Oncopanel_GATCLiquid"	"Responder"	NA	"Lung Adenocarcinoma"	NA	NA	NA	NA	"Strong"	22.03	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	18.38	0	1	0
"3410"	"BioLung_2022"	"BL_110"	"Oncopanel_GATCLiquid"	"Non-Responder"	NA	NA	NA	NA	NA	NA	NA	62.69	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	7.1	2	0	0
"1101"	"Control_cohort"	"P-0000149"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	50	"Female"	"IV"	NA	9.98239770538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"2101"	"Control_cohort"	"P-0000163"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	37	"Female"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"354"	"Control_cohort"	"P-0000252"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	52	"Female"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"411"	"Control_cohort"	"P-0000280"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	54	"Female"	"IA"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"511"	"Control_cohort"	"P-0000301"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	29	"Male"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"611"	"Control_cohort"	"P-0000347"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Female"	"IV"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"711"	"Control_cohort"	"P-0000348"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Male"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"811"	"Control_cohort"	"P-0000352"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	46	"Female"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"911"	"Control_cohort"	"P-0000370"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IV"	NA	9.98239770538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1011"	"Control_cohort"	"P-0000390"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	50	"Male"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1111"	"Control_cohort"	"P-0000395"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	47	"Male"	"IIB"	NA	8.87324240478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	1	0	0
"1211"	"Control_cohort"	"P-0000474"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	31	"Female"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1311"	"Control_cohort"	"P-0000491"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	59	"Male"	"IV"	NA	28.8380378155	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	4	0	0
"1411"	"Control_cohort"	"P-0000557"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	76	"Male"	"IV"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"1511"	"Control_cohort"	"P-0000580"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	68	"Female"	"IV"	NA	9.98239770538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1611"	"Control_cohort"	"P-0000583"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	60	"Female"	"IV"	NA	11.091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"1711"	"Control_cohort"	"P-0000594"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	55	"Male"	"IIIB"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"1811"	"Control_cohort"	"P-0000626"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	65	"Female"	"IV"	NA	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"1911"	"Control_cohort"	"P-0000630"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	66	"Female"	"IV"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2011"	"Control_cohort"	"P-0000636"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	53	"Female"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2111"	"Control_cohort"	"P-0000732"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	75	"Male"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"2211"	"Control_cohort"	"P-0000774"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	74	"Male"	"IV"	NA	11.091553006	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	NA	1	0	2
"2311"	"Control_cohort"	"P-0000785"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	65	"Female"	"IV"	NA	15.5281742084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"2411"	"Control_cohort"	"P-0000819"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	58	"Male"	"IV"	NA	15.5281742084	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"2511"	"Control_cohort"	"P-0000840"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	45	"Female"	"IIIA"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"2611"	"Control_cohort"	"P-0000900"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Male"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2711"	"Control_cohort"	"P-0000929"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	56	"Male"	"IIIA"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2811"	"Control_cohort"	"P-0000987"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	61	"Male"	"IV"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"2911"	"Control_cohort"	"P-0001010"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IIIB"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"3011"	"Control_cohort"	"P-0001037"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	74	"Female"	"IA"	NA	7.76408710418	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"3111"	"Control_cohort"	"P-0001089"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Male"	"IV"	NA	7.76408710418	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"3211"	"Control_cohort"	"P-0001097"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Female"	"IV"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"3311"	"Control_cohort"	"P-0001117"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	80	"Male"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"3411"	"Control_cohort"	"P-0001123"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	71	"Female"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"355"	"Control_cohort"	"P-0001131"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	59	"Female"	"IV"	NA	8.87324240478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"361"	"Control_cohort"	"P-0001189"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	61	"Male"	"IV"	NA	18.8556401102	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"371"	"Control_cohort"	"P-0001224"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Female"	"IIIA"	NA	24.4014166131	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	NA	3	0	0
"381"	"Control_cohort"	"P-0001241"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	83	"Female"	"IB"	NA	4.43662120239	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"391"	"Control_cohort"	"P-0001243"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	61	"Female"	"IV"	NA	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"401"	"Control_cohort"	"P-0001296"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	68	"Female"	"IIA"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"412"	"Control_cohort"	"P-0001300"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	51	"Female"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"421"	"Control_cohort"	"P-0001303"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IV"	NA	9.98239770538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"431"	"Control_cohort"	"P-0001309"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	43	"Female"	"IV"	NA	15.5281742084	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	NA	2	0	1
"441"	"Control_cohort"	"P-0001328"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	78	"Female"	"IV"	NA	8.87324240478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	NA	0	1	1
"451"	"Control_cohort"	"P-0001357"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	69	"Male"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"461"	"Control_cohort"	"P-0001368"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Male"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"471"	"Control_cohort"	"P-0001381"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	66	"Male"	"IV"	NA	11.091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	NA	2	0	1
"481"	"Control_cohort"	"P-0001389"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	45	"Female"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	NA	0	1	1
"491"	"Control_cohort"	"P-0001437"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IIIB"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"501"	"Control_cohort"	"P-0001442"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	56	"Male"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	NA	0	1	1
"512"	"Control_cohort"	"P-0001532"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	51	"Female"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"521"	"Control_cohort"	"P-0001553"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	75	"Female"	"IIIA"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"531"	"Control_cohort"	"P-0001613"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	60	"Female"	"IV"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	0	NA	2	1	1
"541"	"Control_cohort"	"P-0001625"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	62	"Male"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"551"	"Control_cohort"	"P-0001707"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Male"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"561"	"Control_cohort"	"P-0001750"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Female"	"IV"	NA	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	NA	1	0	2
"571"	"Control_cohort"	"P-0001766"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	54	"Female"	"IV"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"581"	"Control_cohort"	"P-0001811"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	49	"Female"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"591"	"Control_cohort"	"P-0001813"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	78	"Male"	"IV"	NA	7.76408710418	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"601"	"Control_cohort"	"P-0001817"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	40	"Female"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"612"	"Control_cohort"	"P-0001826"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Female"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"621"	"Control_cohort"	"P-0001832"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IIA"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"631"	"Control_cohort"	"P-0001833"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Male"	"IV"	NA	13.3098636072	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	4	0	0
"641"	"Control_cohort"	"P-0001840"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	37	"Female"	"IV"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"651"	"Control_cohort"	"P-0001894"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	71	"Female"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"661"	"Control_cohort"	"P-0001927"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	76	"Male"	"IV"	NA	8.87324240478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	3	0	0
"671"	"Control_cohort"	"P-0002000"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IV"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"681"	"Control_cohort"	"P-0002024"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	62	"Male"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"691"	"Control_cohort"	"P-0002026"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	83	"Male"	"IV"	NA	14.4190189078	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	3	0	1
"701"	"Control_cohort"	"P-0002038"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	70	"Female"	"IV"	NA	5.54577650299	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"712"	"Control_cohort"	"P-0002046"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	70	"Male"	"IV"	NA	2.2183106012	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"721"	"Control_cohort"	"P-0002079"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	75	"Male"	"IV"	NA	7.76408710418	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"731"	"Control_cohort"	"P-0002085"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	62	"Female"	"IV"	NA	7.76408710418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	NA	1	1	1
"741"	"Control_cohort"	"P-0002091"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	38	"Female"	"IV"	NA	7.76408710418	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"751"	"Control_cohort"	"P-0002207"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	75	"Male"	"IV"	NA	7.76408710418	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"761"	"Control_cohort"	"P-0002217"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	46	"Male"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"771"	"Control_cohort"	"P-0002218"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	65	"Female"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"781"	"Control_cohort"	"P-0002266"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	67	"Male"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"791"	"Control_cohort"	"P-0002275"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	83	"Female"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"801"	"Control_cohort"	"P-0002309"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	46	"Male"	"IV"	NA	7.76408710418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"812"	"Control_cohort"	"P-0002329"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	58	"Male"	"IV"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"821"	"Control_cohort"	"P-0002403"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Female"	"IIIB"	NA	8.87324240478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"831"	"Control_cohort"	"P-0002408"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	76	"Male"	"IV"	NA	1.1091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	NA	1	0	0
"841"	"Control_cohort"	"P-0002423"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Male"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"851"	"Control_cohort"	"P-0002425"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	23	"Male"	"IV"	NA	11.091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"861"	"Control_cohort"	"P-0002426"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	55	"Female"	"IV"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"871"	"Control_cohort"	"P-0002446"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Male"	"IV"	NA	7.76408710418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"881"	"Control_cohort"	"P-0002489"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	78	"Female"	"IV"	NA	7.76408710418	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	2	0	1
"891"	"Control_cohort"	"P-0002491"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	42	"Female"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"901"	"Control_cohort"	"P-0002506"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"912"	"Control_cohort"	"P-0002523"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	70	"Female"	"IV"	NA	11.091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	3	0	1
"921"	"Control_cohort"	"P-0002524"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	72	"Female"	"IV"	NA	5.54577650299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	NA	0	1	1
"931"	"Control_cohort"	"P-0002534"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	72	"Female"	"IIIA"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"941"	"Control_cohort"	"P-0002557"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	35	"Female"	"IV"	NA	3.32746590179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	NA	1	0	1
"951"	"Control_cohort"	"P-0002580"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	47	"Male"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"961"	"Control_cohort"	"P-0002605"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	77	"Female"	"IV"	NA	11.091553006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	2	0	0
"971"	"Control_cohort"	"P-0002613"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	59	"Female"	"IIIB"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"981"	"Control_cohort"	"P-0002707"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	50	"Female"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"991"	"Control_cohort"	"P-0002768"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	37	"Female"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1001"	"Control_cohort"	"P-0002780"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Female"	"IV"	NA	6.65493180359	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	2	0	1
"1012"	"Control_cohort"	"P-0002783"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Male"	"IV"	NA	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1021"	"Control_cohort"	"P-0002861"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	44	"Female"	"IV"	NA	5.54577650299	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1031"	"Control_cohort"	"P-0002873"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	55	"Male"	"IV"	NA	2.2183106012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"1041"	"Control_cohort"	"P-0002876"	"IMPACT341"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Female"	"IV"	NA	4.43662120239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"1051"	"Control_cohort"	"P-0002877"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	63	"Female"	"IV"	NA	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1061"	"Control_cohort"	"P-0002890"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	37	"Female"	"IV"	NA	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1071"	"Control_cohort"	"P-0003030"	"IMPACT341"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	56	"Female"	"IV"	NA	6.65493180359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1081"	"Control_cohort"	"P-0003070"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	46	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1091"	"Control_cohort"	"P-0003107"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	67	"Male"	"IIA"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"1102"	"Control_cohort"	"P-0003116"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	84	"Female"	"IV"	NA	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"1112"	"Control_cohort"	"P-0003125"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	42	"Male"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"1121"	"Control_cohort"	"P-0003156"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	77	"Male"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"1131"	"Control_cohort"	"P-0003169"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	83	"Male"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1141"	"Control_cohort"	"P-0003206"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	75	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1151"	"Control_cohort"	"P-0003213"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	77	"Female"	"IV"	NA	9.78719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1161"	"Control_cohort"	"P-0003243"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1171"	"Control_cohort"	"P-0003250"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	51	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"1181"	"Control_cohort"	"P-0003274"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	62	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1191"	"Control_cohort"	"P-0003297"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	75	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1201"	"Control_cohort"	"P-0003316"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	71	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	2	0	1
"1212"	"Control_cohort"	"P-0003322"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	71	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1221"	"Control_cohort"	"P-0003357"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	48	"Female"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"1231"	"Control_cohort"	"P-0003383"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	65	"Male"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1241"	"Control_cohort"	"P-0003425"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1251"	"Control_cohort"	"P-0003446"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	34	"Male"	"IIIA"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1261"	"Control_cohort"	"P-0003465"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	78	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1271"	"Control_cohort"	"P-0003479"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	65	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1281"	"Control_cohort"	"P-0003480"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	80	"Female"	"IIIA"	NA	0.978719697615	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1291"	"Control_cohort"	"P-0003502"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	74	"Male"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1301"	"Control_cohort"	"P-0003573"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	70	"Female"	"IA L,IV R"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1312"	"Control_cohort"	"P-0003595"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	58	"Female"	"IV"	NA	8.80847727853	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"1321"	"Control_cohort"	"P-0003635"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	57	"Female"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"1331"	"Control_cohort"	"P-0003666"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	75	"Male"	"IIIA"	NA	9.78719697615	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	NA	2	0	0
"1341"	"Control_cohort"	"P-0003670"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1351"	"Control_cohort"	"P-0003714"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	86	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"1361"	"Control_cohort"	"P-0003735"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	66	"Female"	"IV"	NA	0.978719697615	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1371"	"Control_cohort"	"P-0003750"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IA"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1381"	"Control_cohort"	"P-0003752"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	67	"Female"	"IV"	NA	6.8510378833	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"1391"	"Control_cohort"	"P-0003861"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	68	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"1401"	"Control_cohort"	"P-0003923"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	67	"Female"	"IV"	NA	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	NA	0	1	1
"1412"	"Control_cohort"	"P-0003967"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	69	"Female"	"IIIB"	NA	3.91487879046	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"1421"	"Control_cohort"	"P-0003970"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	44	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"1431"	"Control_cohort"	"P-0004066"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	52	"Male"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1441"	"Control_cohort"	"P-0004108"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	69	"Male"	"IIA"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1451"	"Control_cohort"	"P-0004117"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	55	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	NA	0	1	1
"1461"	"Control_cohort"	"P-0004123"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	68	"Male"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1471"	"Control_cohort"	"P-0004129"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	60	"Male"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"1481"	"Control_cohort"	"P-0004146"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	86	"Male"	"IV"	NA	14.6807954642	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	NA	3	1	1
"1491"	"Control_cohort"	"P-0004218"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	57	"Female"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1501"	"Control_cohort"	"P-0004238"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1512"	"Control_cohort"	"P-0004303"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1521"	"Control_cohort"	"P-0004318"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	73	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1531"	"Control_cohort"	"P-0004328"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	61	"Male"	"IA"	NA	6.8510378833	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1541"	"Control_cohort"	"P-0004344"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	60	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1551"	"Control_cohort"	"P-0004395"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IIIA"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	1	0	1
"1561"	"Control_cohort"	"P-0004421"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	73	"Female"	"IV"	NA	3.91487879046	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"1571"	"Control_cohort"	"P-0004432"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	53	"Male"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1581"	"Control_cohort"	"P-0004516"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	61	"Male"	"IV"	NA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1591"	"Control_cohort"	"P-0004607"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	63	"Male"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	NA	0	0	2
"1601"	"Control_cohort"	"P-0004613"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	60	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1612"	"Control_cohort"	"P-0004695"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Male"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1621"	"Control_cohort"	"P-0004729"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	78	"Female"	"IV"	NA	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"1631"	"Control_cohort"	"P-0004739"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	41	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1641"	"Control_cohort"	"P-0004743"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	73	"Female"	"IB"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1651"	"Control_cohort"	"P-0004790"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	47	"Female"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
"1661"	"Control_cohort"	"P-0004847"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	47	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1671"	"Control_cohort"	"P-0004961"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	67	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1681"	"Control_cohort"	"P-0005017"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	78	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1691"	"Control_cohort"	"P-0005034"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	60	"Male"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	NA	1	1	1
"1701"	"Control_cohort"	"P-0005059"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	29	"Male"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	NA	0	1	1
"1712"	"Control_cohort"	"P-0005063"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	56	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1721"	"Control_cohort"	"P-0005069"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	87	"Male"	"IV"	NA	3.91487879046	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"1731"	"Control_cohort"	"P-0005114"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	39	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1741"	"Control_cohort"	"P-0005123"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	56	"Female"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1751"	"Control_cohort"	"P-0005148"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Male"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1761"	"Control_cohort"	"P-0005223"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1771"	"Control_cohort"	"P-0005264"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	74	"Male"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1781"	"Control_cohort"	"P-0005277"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	37	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1791"	"Control_cohort"	"P-0005286"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	74	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1801"	"Control_cohort"	"P-0005337"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	67	"Male"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1812"	"Control_cohort"	"P-0005393"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	62	"Female"	"IV"	NA	7.82975758092	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	3	0	1
"1821"	"Control_cohort"	"P-0005464"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	65	"Female"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1831"	"Control_cohort"	"P-0005467"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Male"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1841"	"Control_cohort"	"P-0005553"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	48	"Male"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1851"	"Control_cohort"	"P-0005743"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	44	"Male"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"1861"	"Control_cohort"	"P-0005752"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Male"	"IV"	NA	3.91487879046	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1871"	"Control_cohort"	"P-0005895"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	69	"Female"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"1881"	"Control_cohort"	"P-0005974"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	52	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	NA	1	1	1
"1891"	"Control_cohort"	"P-0005985"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	50	"Female"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	NA	2	1	1
"1901"	"Control_cohort"	"P-0006065"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	77	"Female"	"IIIB"	NA	1.95743939523	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"1912"	"Control_cohort"	"P-0006094"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	63	"Female"	"IIIA"	NA	10.7659166738	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	NA	3	0	0
"1921"	"Control_cohort"	"P-0006105"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Male"	"IIA"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	NA	0	1	1
"1931"	"Control_cohort"	"P-0006114"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"1941"	"Control_cohort"	"P-0006116"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	76	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"1951"	"Control_cohort"	"P-0006151"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	53	"Female"	"IIIA"	NA	5.87231818569	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"1961"	"Control_cohort"	"P-0006171"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	48	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"1971"	"Control_cohort"	"P-0006198"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	81	"Female"	"IIIA"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"1981"	"Control_cohort"	"P-0006289"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	63	"Female"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	2	0	0
"1991"	"Control_cohort"	"P-0006397"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	93	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"2001"	"Control_cohort"	"P-0006402"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Female"	"IIIA"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"2012"	"Control_cohort"	"P-0006569"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	56	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2021"	"Control_cohort"	"P-0006606"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	77	"Female"	"IIIA"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2031"	"Control_cohort"	"P-0006671"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	61	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2041"	"Control_cohort"	"P-0006720"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"2051"	"Control_cohort"	"P-0006789"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	61	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2061"	"Control_cohort"	"P-0006810"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	65	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"2071"	"Control_cohort"	"P-0006844"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Female"	"IIIA"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2081"	"Control_cohort"	"P-0006883"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2091"	"Control_cohort"	"P-0006886"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	77	"Male"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2102"	"Control_cohort"	"P-0006915"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	67	"Female"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	NA	0	1	1
"2112"	"Control_cohort"	"P-0006924"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	47	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2121"	"Control_cohort"	"P-0006950"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	61	"Female"	"IIIA"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	NA	1	0	0
"2131"	"Control_cohort"	"P-0006995"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	52	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2141"	"Control_cohort"	"P-0007057"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	71	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2151"	"Control_cohort"	"P-0007082"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	72	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2161"	"Control_cohort"	"P-0007167"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	62	"Male"	"IV"	NA	9.78719697615	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	NA	2	0	1
"2171"	"Control_cohort"	"P-0007239"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	81	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	NA	0	0	1
"2181"	"Control_cohort"	"P-0007322"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	60	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2191"	"Control_cohort"	"P-0007413"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	56	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"2201"	"Control_cohort"	"P-0007507"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	49	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2212"	"Control_cohort"	"P-0007508"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	69	"Male"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2221"	"Control_cohort"	"P-0007580"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	60	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2231"	"Control_cohort"	"P-0007587"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	73	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2241"	"Control_cohort"	"P-0007663"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	72	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2251"	"Control_cohort"	"P-0007681"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	71	"Male"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2261"	"Control_cohort"	"P-0007745"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	42	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2271"	"Control_cohort"	"P-0007754"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	75	"Male"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"2281"	"Control_cohort"	"P-0007775"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	73	"Female"	"IB"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2291"	"Control_cohort"	"P-0007788"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	63	"Female"	"IV"	NA	10.7659166738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	NA	2	0	1
"2301"	"Control_cohort"	"P-0007841"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	44	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2312"	"Control_cohort"	"P-0007864"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	40	"Female"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2321"	"Control_cohort"	"P-0007870"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	37	"Male"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2331"	"Control_cohort"	"P-0007904"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	85	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2341"	"Control_cohort"	"P-0008078"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	74	"Female"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2351"	"Control_cohort"	"P-0008101"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	66	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"2361"	"Control_cohort"	"P-0008134"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	48	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	1	0	0
"2371"	"Control_cohort"	"P-0008282"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	61	"Male"	"IV"	NA	6.8510378833	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"2381"	"Control_cohort"	"P-0008310"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	63	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2391"	"Control_cohort"	"P-0008426"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	68	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	NA	0	1	1
"2401"	"Control_cohort"	"P-0008442"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	64	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2412"	"Control_cohort"	"P-0008476"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	64	"Female"	"IIA"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	NA	1	0	2
"2421"	"Control_cohort"	"P-0008549"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	61	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	1	0	1
"2431"	"Control_cohort"	"P-0008599"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	75	"Male"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2441"	"Control_cohort"	"P-0008602"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	54	"Female"	"IV"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2451"	"Control_cohort"	"P-0008665"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	55	"Male"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2461"	"Control_cohort"	"P-0008678"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	71	"Female"	"IIIA"	NA	7.82975758092	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	3	0	0
"2471"	"Control_cohort"	"P-0008744"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	65	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2481"	"Control_cohort"	"P-0008756"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	66	"Female"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	NA	2	1	0
"2491"	"Control_cohort"	"P-0008764"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	66	"Male"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"2501"	"Control_cohort"	"P-0008765"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Male"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	2	0	1
"2512"	"Control_cohort"	"P-0008849"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	50	"Female"	"IV"	NA	5.87231818569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"2521"	"Control_cohort"	"P-0008855"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	34	"Female"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2531"	"Control_cohort"	"P-0008917"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	67	"Female"	"IV"	NA	7.82975758092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2541"	"Control_cohort"	"P-0008934"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	49	"Female"	"IIA"	NA	2.93615909284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2551"	"Control_cohort"	"P-0009172"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	59	"Female"	"IIA"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2561"	"Control_cohort"	"P-0009301"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	69	"Male"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	NA	0	1	0
"2571"	"Control_cohort"	"P-0009339"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	16	"Female"	"IIB"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	0	0	0
"2581"	"Control_cohort"	"P-0009343"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	50	"Male"	"IV"	NA	6.8510378833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"2591"	"Control_cohort"	"P-0009346"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	NA	0	0	1
"2601"	"Control_cohort"	"P-0009353"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	37	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"2612"	"Control_cohort"	"P-0009514"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	57	"Male"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	NA	1	0	0
"2621"	"Control_cohort"	"P-0009535"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	58	"Female"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	NA	2	0	1
"2631"	"Control_cohort"	"P-0009608"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Former"	72	"Male"	"IV"	NA	3.91487879046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	NA	2	0	1
"2641"	"Control_cohort"	"P-0009661"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	54	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2651"	"Control_cohort"	"P-0009704"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	63	"Male"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2661"	"Control_cohort"	"P-0009708"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	59	"Female"	"IIIB"	NA	12.723356069	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0	NA	3	0	2
"2671"	"Control_cohort"	"P-0009824"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	57	"Female"	"IV"	NA	8.80847727853	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	1	0	1
"2681"	"Control_cohort"	"P-0009861"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	86	"Female"	"IV"	NA	1.95743939523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	NA	0	0	1
"2691"	"Control_cohort"	"P-0009928"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Never"	70	"Female"	"IV"	NA	4.89359848807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	NA	0	0	1
"2701"	"Control_cohort"	"P-0010041"	"IMPACT410"	"Responder"	NA	"Lung Adenocarcinoma"	"Never"	46	"Male"	"IV"	NA	0.978719697615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	0	0	0
"2712"	"Control_cohort"	"P-0010466"	"IMPACT410"	"Non-Responder"	NA	"Lung Adenocarcinoma"	"Former"	60	"Female"	"IV"	NA	1.95743939523	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	2	0	0
